Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) (CANTOS)

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2016 by Novartis
Sponsor:
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )
ClinicalTrials.gov Identifier:
NCT01327846
First received: March 29, 2011
Last updated: April 5, 2016
Last verified: April 2016
  Purpose

Main Study (CACZ885M2301) The purpose of this trial is to test the hypothesis that canakinumab treatment of patients with MI at least one month prior to study entry and elevated hsCRP will prevent recurrent cardiovascular events.

Sub-study 1 (CACZ885M2301S1) The purpose of this sub-study is to evaluate the effect of quarterly subcutaneous canakinumab treatment for 24 months comparted with placebo on the carotid plaque burden measured by integrated vascular MRI in patients enrolled in the CACZ885M2301 study (CANTOS).

Sub-study 2 (CACZ885M2301S2) The purpose of this CANTOS sub-study is to determine whether, in patients with type 2 diabetes participating in the CANTOS main study, canakinumab compared to placebo, on top of standard of care increases insulin secretion and insulin sensitivity.


Condition Intervention Phase
Atherosclerosis
Drug: Canakinumab
Drug: Placebo
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Randomized, Double-blind, Placebo-controlled, Event Driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-Myocardial Infarction Patients With Elevated hsCRP Including Substudies to Evaluate the Effect of Canakinumab on Carotid Atherosclerosis, and on Glucose Control Following OGTT in T2DM

Resource links provided by NLM:


Further study details as provided by Novartis:

Primary Outcome Measures:
  • Main:Time to first occurrence of major adverse cardiovascular event, which is a composite of CV death, non-fatal MI, and stroke. [ Time Frame: 36 months ] [ Designated as safety issue: No ]
  • Substudy 1; Change from baseline in carotid plaque burden in the bifurcation region of the index carotid artery [ Time Frame: 36 months ] [ Designated as safety issue: No ]
  • Substudy 2; Change from baseline of the insulin secretion rate (ISR) relative to glucose 0-30 min defined as Φ30 = AUCISR 0-30 / AUCGluc 0-30 averaged across the yearly visits. [ Time Frame: 36 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Main:Time to first occurrence of the composite cardiovascular endpoint consisting of cardiovascular death, non-fatal MI, stroke and hospitalization for unstable angina requiring unplanned revascularization. [ Time Frame: 36 months ] [ Designated as safety issue: No ]
  • Main:Time to new onset type 2 diabetes among patients with pre-diabetes at randomization. [ Time Frame: 36 months ] [ Designated as safety issue: No ]
  • Main:Time to first occurrence of non-fatal MI, stroke and all-cause mortality composite. [ Time Frame: 36 months ] [ Designated as safety issue: No ]
  • Main: Time to all-cause mortality. [ Time Frame: 36 months ] [ Designated as safety issue: No ]
  • Substudy 1; Change from baseline of the total vessel wall area at Month 3 of the index carotid artery. [ Time Frame: 36 months ] [ Designated as safety issue: No ]
  • Substudy 1; Mean total vessel wall area across the left and right carotid artery at Month 3 and Month 24. [ Time Frame: 36 months ] [ Designated as safety issue: No ]
  • Substudy 1; Change from baseline in corresponding total vessel wall area in the left and right carotid arteries. [ Time Frame: 36 months ] [ Designated as safety issue: No ]
  • Substudy 1; The existence of a baseline total vessel wall area by treatment interaction as well as the consistency of the treatment effect across subgroups. [ Time Frame: 36 months ] [ Designated as safety issue: No ]
  • Substudy 2; Change from baseline in insulin sensitivity index. [ Time Frame: 36 months ] [ Designated as safety issue: No ]
  • Substudy 2; Change from baseline in OGTT stimulated area under curve (AUC) 0-120 min of glucose concentration, insulin concentration, pro-insulin concentration, and insulin concentration/glucose concentration ratio. [ Time Frame: 36 months ] [ Designated as safety issue: No ]
  • Substudy 2; Change from baseline in fasting pro-insulin concentration /insulin concentration ratio. [ Time Frame: 36 months ] [ Designated as safety issue: No ]
  • Substudy 2; Change from baseline in OGTT stimulated area under the curve (AUC) 0-120 min of C-peptide concentration. [ Time Frame: 36 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 10000
Study Start Date: April 2011
Estimated Study Completion Date: April 2017
Estimated Primary Completion Date: April 2017 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Canakinumab 50 mg
Description: Canakinumab 50 mg quarterly subcutaneous + standard of care therapy.
Drug: Canakinumab
Experimental: Canakinumab Dose 150 mg
Description: Canakinumab 150 mg quarterly subcutaneous + standard of care therapy.
Drug: Canakinumab
Experimental: Canakinumab Dose 300 mg
Description: Canakinumab 300 mg quarterly subcutaneous + standard of care therapy.
Drug: Canakinumab
Placebo Comparator: Placebo
Description: Matching placebo quarterly subcutaneous + standard of care therapy.
Drug: Placebo

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Main Study Inclusion Criteria:

  • Written informed consent
  • Male, or Female of non-child-bearing potential
  • Age ≥ 18 years.
  • Spontaneous MI at least 30 days before randomization. hsCRP ≥ 2 mg/L

Substudy 1 Inclusion:

  • All Inclusion from Main Study
  • Acquisition of evaluable baseline MRI images of bilateral carotid arteries by the imaging core laboratory

Substudy 2 Inclusion:

  • All inclusion from Main Study
  • T2D at baseline per Main protocol criteria and be on a stable anti-hyperglycemic medication for at least 4 weeks prior to the baseline OGTT test
  • Willing to have the OGTT assessment started before 10 am

Main Study Exclusion Criteria:

  • Pregnant or nursing (lactating) women
  • Women of child-bearing potential
  • Any of the following concomitant diseases
  • Planned coronary revascularization (PCI or CABG)
  • Major non-cardiac surgical or endoscopic procedure within past 6 months
  • Multi-vessel CABG surgery within the past 3 years
  • Symptomatic patients with Class IV heart failure (HF) (New York Heart Association [NYHA].
  • Uncontrolled hypertension
  • Uncontrolled diabetes
  • History or evidence of active tuberculosis (TB) infection Substudy 1 Exclusion
  • All Main exclusion
  • Patients with prior history of carotid angioplasty, stenting, or carotid atherectomy
  • Patients with contraindications to MRI examination (brain aneurysm clip, implanted neural stimulator, implanted cardiac pacemaker, pacemaker wires or defibrillator, prosthetic heart valves, cochlear implant, ocular foreign body or other implanted body, tattoos, implanted insulin pump, metal shrapnel or bullet)
  • Patients prone to claustrophobia or known anxiety disorders
  • BMI > 40 kg/m2 Substudy 2 Exclusion
  • This sub-study does not have any additional exclusion criteria. Other protocol-defined inclusion/exclusion criteria may apply
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01327846

Contacts
Contact: Novartis Pharmaceuticals 1-888-669-6682
Contact: Novartis Pharmaceuticals

  Hide Study Locations
Locations
United States, Alabama
Novartis Investigative Site Terminated
Athens, Alabama, United States, 35611
Novartis Investigative Site Active, not recruiting
Birmingham, Alabama, United States, 35209
Novartis Investigative Site Terminated
Birmingham, Alabama, United States, 35209
Novartis Investigative Site Active, not recruiting
Birmingham, Alabama, United States, 35235-3424
Novartis Investigative Site Active, not recruiting
Birmingham, Alabama, United States, 35294-2041
Novartis Investigative Site Terminated
Fairhope, Alabama, United States, 36532
Novartis Investigative Site Active, not recruiting
Huntsville, Alabama, United States, 35801
Novartis Investigative Site Active, not recruiting
Mobile, Alabama, United States, 36604
Novartis Investigative Site Active, not recruiting
Mobile, Alabama, United States, 36608
Novartis Investigative Site Terminated
Mobile, Alabama, United States, 36617-2293
United States, Alaska
Novartis Investigative Site Active, not recruiting
Anchorage, Alaska, United States, 99508
United States, Arizona
Novartis Investigative Site Withdrawn
Bullhead City, Arizona, United States, 86442
Novartis Investigative Site Terminated
Chandler, Arizona, United States, 85224
Novartis Investigative Site Active, not recruiting
Glendale, Arizona, United States, 85302
Novartis Investigative Site Active, not recruiting
Phoenix, Arizona, United States, 85018
Novartis Investigative Site Active, not recruiting
Phoenix, Arizona, United States, 85032
Novartis Investigative Site Withdrawn
Tucson, Arizona, United States, 85712
United States, Arkansas
Novartis Investigative Site Active, not recruiting
Hot Springs, Arkansas, United States, 71913
Novartis Investigative Site Active, not recruiting
Jonesboro, Arkansas, United States, 72401
Novartis Investigative Site Withdrawn
Little Rock, Arkansas, United States, 72204
Novartis Investigative Site Active, not recruiting
Little Rock, Arkansas, United States, 72204
Novartis Investigative Site Withdrawn
Little Rock, Arkansas, United States, 72211
Novartis Investigative Site Withdrawn
Whitehall, Arkansas, United States, 71602
United States, California
Novartis Investigative Site Active, not recruiting
Beverly Hills, California, United States, 90211
Novartis Investigative Site Active, not recruiting
Carmichael, California, United States, 95608
Novartis Investigative Site Active, not recruiting
Escondido, California, United States, 92025
Novartis Investigative Site Active, not recruiting
Fullerton, California, United States, 92835
Novartis Investigative Site Active, not recruiting
Huntington Beach, California, United States, 92647
Novartis Investigative Site Withdrawn
Huntington Park, California, United States, 90255
Novartis Investigative Site Active, not recruiting
Lancaster, California, United States, 93534
Novartis Investigative Site Terminated
Loma Linda, California, United States, 92354
Novartis Investigative Site Active, not recruiting
Loma Linda, California, United States, 92357
Novartis Investigative Site Active, not recruiting
Long Beach, California, United States, 90806
Novartis Investigative Site Active, not recruiting
Los Angeles, California, United States, 90033
Novartis Investigative Site Active, not recruiting
Los Angeles, California, United States, 90073
Novartis Investigative Site Active, not recruiting
Los Gatos, California, United States, 95032
Novartis Investigative Site Active, not recruiting
Mission Viejo, California, United States, 92691
Novartis Investigative Site Active, not recruiting
Newport Beach, California, United States, 92663
Novartis Investigative Site Withdrawn
Northridge, California, United States, 91325
Novartis Investigative Site Active, not recruiting
Northridge, California, United States, 91325
Novartis Investigative Site Active, not recruiting
Oceanside, California, United States, 92056
Novartis Investigative Site Withdrawn
Orange, California, United States, 92868
Novartis Investigative Site Active, not recruiting
Orangevale, California, United States, 95662
Novartis Investigative Site Active, not recruiting
Palm Spring, California, United States, 92262
Novartis Investigative Site Active, not recruiting
Palm Springs, California, United States, 92262
Novartis Investigative Site Active, not recruiting
Pasadena, California, United States, 91105
Novartis Investigative Site Active, not recruiting
Pomona, California, United States, 91767
Novartis Investigative Site Withdrawn
Redondo Beach, California, United States, 90277
Novartis Investigative Site Withdrawn
Sacramento, California, United States, 95817
Novartis Investigative Site Active, not recruiting
Sacramento, California, United States, 95816
Novartis Investigative Site Terminated
Sacramento, California, United States, 95816
Novartis Investigative Site Active, not recruiting
Sacramento, California, United States, 95819
Novartis Investigative Site Active, not recruiting
San Diego, California, United States, 92101
Novartis Investigative Site Active, not recruiting
San Diego, California, United States, 92108
Novartis Investigative Site Terminated
San Diego, California, United States, 92120
Novartis Investigative Site Withdrawn
San Diego, California, United States, 92121
Novartis Investigative Site Active, not recruiting
San Diego, California, United States, 92128
Novartis Investigative Site Active, not recruiting
San Diego, California, United States, 92161
Novartis Investigative Site Terminated
San Francisco, California, United States, 94143-0792
Novartis Investigative Site Withdrawn
San Pedro, California, United States, 90732
Novartis Investigative Site Active, not recruiting
Santa Ana, California, United States, 92704
Novartis Investigative Site Active, not recruiting
Santa Rosa, California, United States, 95405
Novartis Investigative Site Withdrawn
Temecula, California, United States, 92591
Novartis Investigative Site Active, not recruiting
Torrance, California, United States, 90502
Novartis Investigative Site Active, not recruiting
Tustin, California, United States, 92780
Novartis Investigative Site Active, not recruiting
Visalia, California, United States, 93291
Novartis Investigative Site Active, not recruiting
Walnut Creek, California, United States, 94598
Novartis Investigative Site Withdrawn
Westlake Village, California, United States, 91361
United States, Colorado
Novartis Investigative Site Active, not recruiting
Aurora, Colorado, United States, 80012
Novartis Investigative Site Terminated
Colorado Springs, Colorado, United States, 80907
Novartis Investigative Site Active, not recruiting
Denver, Colorado, United States, 80204-4507
Novartis Investigative Site Active, not recruiting
Denver, Colorado, United States, 80206
Novartis Investigative Site Active, not recruiting
Denver, Colorado, United States, 80218
Novartis Investigative Site Active, not recruiting
Denver, Colorado, United States, 80220
Novartis Investigative Site Withdrawn
Longmount, Colorado, United States, 80501
United States, Connecticut
Novartis Investigative Site Completed
Norwich, Connecticut, United States, 06360
United States, Delaware
Novartis Investigative Site Active, not recruiting
Newark, Delaware, United States, 19713
United States, District of Columbia
Novartis Investigative Site Active, not recruiting
Washington, District of Columbia, United States, 20010
Novartis Investigative Site Active, not recruiting
Washington, District of Columbia, United States, 20037
Novartis Investigative Site Withdrawn
Washington, District of Columbia, United States, 20422
United States, Florida
Novartis Investigative Site Withdrawn
Aventura, Florida, United States, 33180
Novartis Investigative Site Active, not recruiting
Clearwater, Florida, United States, 33756
Novartis Investigative Site Active, not recruiting
Coral Springs, Florida, United States, 33065
Novartis Investigative Site Terminated
Davie, Florida, United States, 33324
Novartis Investigative Site Active, not recruiting
Daytona Beach, Florida, United States, 32114
Novartis Investigative Site Active, not recruiting
Defuniak Springs, Florida, United States, 32435
Novartis Investigative Site Active, not recruiting
Doral, Florida, United States, 33136
Novartis Investigative Site Terminated
Hialeah, Florida, United States, 33012
Novartis Investigative Site Active, not recruiting
Hollywood, Florida, United States, 33021
Novartis Investigative Site Active, not recruiting
Hollywood, Florida, United States, 33321
Novartis Investigative Site Active, not recruiting
Jacksonville, Florida, United States, 32209-6511
Novartis Investigative Site Active, not recruiting
Jacksonville, Florida, United States, 32216
Novartis Investigative Site Active, not recruiting
Jacksonville, Florida, United States, 32223
Novartis Investigative Site Active, not recruiting
Jacksonville Beach, Florida, United States, 32050
Novartis Investigative Site Active, not recruiting
Jupiter, Florida, United States, 33458
Novartis Investigative Site Active, not recruiting
Miami, Florida, United States, 33176
Novartis Investigative Site Withdrawn
Miami, Florida, United States, 33176
Novartis Investigative Site Active, not recruiting
Miami, Florida, United States, 33135
Novartis Investigative Site Active, not recruiting
Miami, Florida, United States, 33155
Novartis Investigative Site Active, not recruiting
Miami, Florida, United States, 33126
Novartis Investigative Site Active, not recruiting
Miami Beach, Florida, United States, 33140
Novartis Investigative Site Active, not recruiting
Naples, Florida, United States, 34119
Novartis Investigative Site Active, not recruiting
Orlando, Florida, United States, 32822
Novartis Investigative Site Withdrawn
Palm Beach Gardens, Florida, United States, 33410
Novartis Investigative Site Active, not recruiting
Pembroke Pines, Florida, United States, 33024
Novartis Investigative Site Active, not recruiting
Pinellas Park, Florida, United States, 33781
Novartis Investigative Site Active, not recruiting
Port Charlotte, Florida, United States, 33952
Novartis Investigative Site Active, not recruiting
Port Orange, Florida, United States, 32127
Novartis Investigative Site Active, not recruiting
Sarasota, Florida, United States, 34239
Novartis Investigative Site Active, not recruiting
South Miami, Florida, United States, 33143
Novartis Investigative Site Withdrawn
Tallahassee, Florida, United States, 32308
Novartis Investigative Site Active, not recruiting
Tampa, Florida, United States, 33624
Novartis Investigative Site Withdrawn
Tampa, Florida, United States, 33612
Novartis Investigative Site Active, not recruiting
Tampa, Florida, United States, 33613
Novartis Investigative Site Withdrawn
Tampa, Florida, United States, 33609
Novartis Investigative Site Withdrawn
Trinity, Florida, United States, 34655
Novartis Investigative Site Active, not recruiting
Wellington, Florida, United States, 33449
United States, Georgia
Novartis Investigative Site Active, not recruiting
Athens, Georgia, United States, 30606
Novartis Investigative Site Active, not recruiting
Augusta, Georgia, United States, 30904
Novartis Investigative Site Active, not recruiting
Covington, Georgia, United States, 30014
Novartis Investigative Site Active, not recruiting
Cumming, Georgia, United States, 30041
Novartis Investigative Site Active, not recruiting
Decatur, Georgia, United States, 30033
Novartis Investigative Site Active, not recruiting
Decatur, Georgia, United States, 30035
Novartis Investigative Site Active, not recruiting
Duluth, Georgia, United States, 30096
Novartis Investigative Site Active, not recruiting
Macon, Georgia, United States, 31201
Novartis Investigative Site Active, not recruiting
Roswell, Georgia, United States, 30076
Novartis Investigative Site Terminated
Savannah, Georgia, United States, 31406
Novartis Investigative Site Active, not recruiting
Thomasville, Georgia, United States, 31792
United States, Hawaii
Novartis Investigative Site Active, not recruiting
Honolulu, Hawaii, United States, 96814
United States, Idaho
Novartis Investigative Site Active, not recruiting
Coeur D Alene, Idaho, United States, 83814
United States, Illinois
Novartis Investigative Site Active, not recruiting
Chicago, Illinois, United States, 60611
Novartis Investigative Site Active, not recruiting
Jerseyville, Illinois, United States, 62052
Novartis Investigative Site Active, not recruiting
Lombard, Illinois, United States, 60148
Novartis Investigative Site Terminated
Melrose Park, Illinois, United States, 60160
Novartis Investigative Site Active, not recruiting
Peoria, Illinois, United States, 61602
United States, Indiana
Novartis Investigative Site Withdrawn
Anderson, Indiana, United States, 46011
Novartis Investigative Site Active, not recruiting
Evansville, Indiana, United States, 47712
Novartis Investigative Site Active, not recruiting
Evansville, Indiana, United States, 47714
Novartis Investigative Site Withdrawn
Indianapolis, Indiana, United States, 46260
United States, Iowa
Novartis Investigative Site Active, not recruiting
Ames, Iowa, United States, 50010
Novartis Investigative Site Active, not recruiting
Waterloo, Iowa, United States, 50702
United States, Kansas
Novartis Investigative Site Withdrawn
Kansas City, Kansas, United States, 66160
Novartis Investigative Site Active, not recruiting
Kansas City, Kansas, United States, 66160
Novartis Investigative Site Withdrawn
Lansing, Kansas, United States, 66043
Novartis Investigative Site Terminated
Overland Park, Kansas, United States, 66204
Novartis Investigative Site Active, not recruiting
Topeka, Kansas, United States, 66606
Novartis Investigative Site Active, not recruiting
Wichita, Kansas, United States, 67207
Novartis Investigative Site Active, not recruiting
Wichita, Kansas, United States, 67214
United States, Kentucky
Novartis Investigative Site Active, not recruiting
Lexington, Kentucky, United States, 40509
Novartis Investigative Site Withdrawn
Louisville, Kentucky, United States, 40205
Novartis Investigative Site Active, not recruiting
Louisville, Kentucky, United States, 40206
Novartis Investigative Site Terminated
Madisonville, Kentucky, United States, 42431
Novartis Investigative Site Active, not recruiting
Owensboro, Kentucky, United States, 42303
United States, Louisiana
Novartis Investigative Site Active, not recruiting
Baton Rouge, Louisiana, United States, 70808
Novartis Investigative Site Withdrawn
Baton Rouge, Louisiana, United States, 70808
Novartis Investigative Site Terminated
Baton Rouge, Louisiana, United States, 70816
Novartis Investigative Site Active, not recruiting
Covington, Louisiana, United States, 70433
Novartis Investigative Site Active, not recruiting
Houma, Louisiana, United States, 70360
Novartis Investigative Site Terminated
Lafayette, Louisiana, United States, 70508
Novartis Investigative Site Active, not recruiting
Lafayette, Louisiana, United States, 70501
Novartis Investigative Site Active, not recruiting
Lafayette, Louisiana, United States, 70503
Novartis Investigative Site Withdrawn
Lafayette, Louisiana, United States, 70506
Novartis Investigative Site Withdrawn
Lafayette, Louisiana, United States, 70501
Novartis Investigative Site Active, not recruiting
Mandeville, Louisiana, United States, 70471
Novartis Investigative Site Active, not recruiting
Metairie, Louisiana, United States, 70006
Novartis Investigative Site Active, not recruiting
New Orleans, Louisiana, United States, 70112
Novartis Investigative Site Active, not recruiting
New Orleans, Louisiana, United States, 70115
Novartis Investigative Site Active, not recruiting
New Orleans, Louisiana, United States, 70119
Novartis Investigative Site Terminated
Opelousas, Louisiana, United States, 70570
Novartis Investigative Site Withdrawn
Opelousas, Louisiana, United States, 70570
Novartis Investigative Site Active, not recruiting
Opelousas, Louisiana, United States, 70570
Novartis Investigative Site Active, not recruiting
Shreveport, Louisiana, United States, 71101
Novartis Investigative Site Active, not recruiting
Slidell, Louisiana, United States, 70458
Novartis Investigative Site Active, not recruiting
Winnsboro, Louisiana, United States, 71295
Novartis Investigative Site Active, not recruiting
Zachary, Louisiana, United States, 70791
United States, Maine
Novartis Investigative Site Active, not recruiting
Portland, Maine, United States, 04102
United States, Maryland
Novartis Investigative Site Withdrawn
Annapolis, Maryland, United States, 21401
Novartis Investigative Site Active, not recruiting
Baltimore, Maryland, United States, 21204
Novartis Investigative Site Withdrawn
Baltimore, Maryland, United States, 21218
Novartis Investigative Site Active, not recruiting
Beltsville, Maryland, United States, 20705
Novartis Investigative Site Active, not recruiting
Columbia, Maryland, United States, 21044
Novartis Investigative Site Withdrawn
Lutherville Timonium, Maryland, United States, 21093
Novartis Investigative Site Withdrawn
Nottingham, Maryland, United States, 21236
Novartis Investigative Site Withdrawn
Rockville, Maryland, United States, 20852
United States, Massachusetts
Novartis Investigative Site Terminated
Burlington, Massachusetts, United States, 01803
Novartis Investigative Site Active, not recruiting
Fall River, Massachusetts, United States, 02720
Novartis Investigative Site Active, not recruiting
Haverhill, Massachusetts, United States, 01830
Novartis Investigative Site Withdrawn
Hyannis, Massachusetts, United States, 02601
Novartis Investigative Site Withdrawn
Natick, Massachusetts, United States, 01760
Novartis Investigative Site Withdrawn
North Dartmouth, Massachusetts, United States, 02747
United States, Michigan
Novartis Investigative Site Active, not recruiting
Ann Arbor, Michigan, United States, 48106
Novartis Investigative Site Active, not recruiting
Chelsea, Michigan, United States, 48118
Novartis Investigative Site Active, not recruiting
Detroit, Michigan, United States, 48202
Novartis Investigative Site Active, not recruiting
Grand Blanc, Michigan, United States, 48439
Novartis Investigative Site Active, not recruiting
Kalamazoo, Michigan, United States, 49008
Novartis Investigative Site Active, not recruiting
Midland, Michigan, United States, 48640
Novartis Investigative Site Active, not recruiting
Novi, Michigan, United States, 48374
Novartis Investigative Site Active, not recruiting
Petoskey, Michigan, United States, 49770
Novartis Investigative Site Active, not recruiting
Royal Oak, Michigan, United States, 48073
Novartis Investigative Site Active, not recruiting
Saginaw, Michigan, United States, 48601
Novartis Investigative Site Withdrawn
Troy, Michigan, United States, 48085
Novartis Investigative Site Active, not recruiting
Wyoming, Michigan, United States, 49519
United States, Minnesota
Novartis Investigative Site Withdrawn
Baxter, Minnesota, United States, 56425
Novartis Investigative Site Active, not recruiting
Bloomington, Minnesota, United States, 55420
Novartis Investigative Site Active, not recruiting
Duluth, Minnesota, United States, 55805
Novartis Investigative Site Active, not recruiting
Edina, Minnesota, United States, 55435
Novartis Investigative Site Active, not recruiting
Fridley, Minnesota, United States, 55432
Novartis Investigative Site Withdrawn
Minneapolis, Minnesota, United States, 55416
Novartis Investigative Site Withdrawn
Minneapolis, Minnesota, United States, 55417
Novartis Investigative Site Active, not recruiting
Minneapolis, Minnesota, United States, 55433
Novartis Investigative Site Active, not recruiting
Robbinsdale, Minnesota, United States, 55422
Novartis Investigative Site Active, not recruiting
St. Cloud, Minnesota, United States, 56303
Novartis Investigative Site Active, not recruiting
St. Paul, Minnesota, United States, 55102
United States, Mississippi
Novartis Investigative Site Terminated
Hattiesburg, Mississippi, United States, 39401
Novartis Investigative Site Active, not recruiting
Jackson, Mississippi, United States, 39209
Novartis Investigative Site Active, not recruiting
Picayune, Mississippi, United States, 39466
Novartis Investigative Site Completed
Picayune, Mississippi, United States, 39466
United States, Missouri
Novartis Investigative Site Withdrawn
Chesterfield, Missouri, United States, 63017
Novartis Investigative Site Active, not recruiting
Columbia, Missouri, United States, 65212
Novartis Investigative Site Active, not recruiting
Kansas City, Missouri, United States, 64111
Novartis Investigative Site Active, not recruiting
Saint Louis, Missouri, United States, 63128
Novartis Investigative Site Active, not recruiting
Springfield, Missouri, United States, 65807
Novartis Investigative Site Terminated
Springfield, Missouri, United States, 65807
Novartis Investigative Site Active, not recruiting
St. Louis, Missouri, United States, 63128
Novartis Investigative Site Active, not recruiting
St. Louis, Missouri, United States, 63141
Novartis Investigative Site Active, not recruiting
St. Louis, Missouri, United States, 63110
United States, Nebraska
Novartis Investigative Site Active, not recruiting
Grand Island, Nebraska, United States, 68803
Novartis Investigative Site Active, not recruiting
Lincoln, Nebraska, United States, 68516
Novartis Investigative Site Withdrawn
Omaha, Nebraska, United States, 68198
Novartis Investigative Site Active, not recruiting
Omaha, Nebraska, United States, 68114
Novartis Investigative Site Withdrawn
Omaha, Nebraska, United States, 68124
Novartis Investigative Site Active, not recruiting
Omaha, Nebraska, United States, 68131
Novartis Investigative Site Active, not recruiting
Omaha, Nebraska, United States, 68134
Novartis Investigative Site Terminated
Omaha, Nebraska, United States, 68114
United States, New Hampshire
Novartis Investigative Site Active, not recruiting
Nashua, New Hampshire, United States, 03060
United States, New Jersey
Novartis Investigative Site Active, not recruiting
Camden, New Jersey, United States, 08103
Novartis Investigative Site Withdrawn
Elmer, New Jersey, United States, 08318
Novartis Investigative Site Terminated
Freehold, New Jersey, United States, 07728
Novartis Investigative Site Withdrawn
Haddon Heights, New Jersey, United States, 08035
Novartis Investigative Site Terminated
Lodi, New Jersey, United States, 07644
Novartis Investigative Site Recruiting
New Brunswick, New Jersey, United States, 08901
Novartis Investigative Site Active, not recruiting
Ocean, New Jersey, United States, 07712
Novartis Investigative Site Active, not recruiting
Pomona, New Jersey, United States, 08240
Novartis Investigative Site Active, not recruiting
Ridgewood, New Jersey, United States, 07450
Novartis Investigative Site Active, not recruiting
Westwood, New Jersey, United States, 07675
United States, New Mexico
Novartis Investigative Site Active, not recruiting
Albuquerque, New Mexico, United States, 87102
United States, New York
Novartis Investigative Site Withdrawn
Albany, New York, United States, 12208
Novartis Investigative Site Active, not recruiting
Binghamton, New York, United States, 13901
Novartis Investigative Site Withdrawn
Brooklyn, New York, United States, 11215
Novartis Investigative Site Withdrawn
Buffalo, New York, United States, 14209
Novartis Investigative Site Active, not recruiting
Endwell, New York, United States, 13760
Novartis Investigative Site Active, not recruiting
Kew Gardens, New York, United States, 11415
Novartis Investigative Site Withdrawn
Laurelton, New York, United States, 11422
Novartis Investigative Site Active, not recruiting
Mineola, New York, United States, 11501
Novartis Investigative Site Withdrawn
Mineola, New York, United States, 11501
Novartis Investigative Site Withdrawn
New Windsor, New York, United States, 12553
Novartis Investigative Site Terminated
New York, New York, United States, 10003
Novartis Investigative Site Terminated
New York, New York, United States, 10016
Novartis Investigative Site Active, not recruiting
New York, New York, United States, 10035
Novartis Investigative Site Active, not recruiting
Rochester, New York, United States, 14609
Novartis Investigative Site Active, not recruiting
Rochester, New York, United States, 14621
Novartis Investigative Site Withdrawn
Valhalla, New York, United States, 10595
United States, North Carolina
Novartis Investigative Site Active, not recruiting
Asheboro, North Carolina, United States, 27204
Novartis Investigative Site Withdrawn
Calabash, North Carolina, United States, 28467
Novartis Investigative Site Terminated
Charlotte, North Carolina, United States, 28277
Novartis Investigative Site Active, not recruiting
Greensboro, North Carolina, United States, 27401
Novartis Investigative Site Active, not recruiting
Greensboro, North Carolina, United States, 27408
Novartis Investigative Site Recruiting
Greenville, North Carolina, United States, 27834
Novartis Investigative Site Active, not recruiting
Hickory, North Carolina, United States, 28601
Novartis Investigative Site Active, not recruiting
Mooresville, North Carolina, United States, 28117
Novartis Investigative Site Active, not recruiting
Pinehurst, North Carolina, United States, 28374
Novartis Investigative Site Withdrawn
Raleigh, North Carolina, United States, 27610
Novartis Investigative Site Withdrawn
Rocky Mount, North Carolina, United States, 27804
Novartis Investigative Site Active, not recruiting
Salisbury, North Carolina, United States, 28144
Novartis Investigative Site Active, not recruiting
Sanford, North Carolina, United States, 27330
Novartis Investigative Site Active, not recruiting
Statesville, North Carolina, United States, 28625
Novartis Investigative Site Withdrawn
Tabor City, North Carolina, United States, 28463
Novartis Investigative Site Active, not recruiting
Winston Salem, North Carolina, United States, 27103
Novartis Investigative Site Terminated
Winston Salem, North Carolina, United States, 27106
United States, North Dakota
Novartis Investigative Site Active, not recruiting
Fargo, North Dakota, United States, 58122
Novartis Investigative Site Active, not recruiting
Grand Forks, North Dakota, United States, 58201
United States, Ohio
Novartis Investigative Site Active, not recruiting
Akron, Ohio, United States, 44309
Novartis Investigative Site Active, not recruiting
Cincinnati, Ohio, United States, 45219
Novartis Investigative Site Active, not recruiting
Cincinnati, Ohio, United States, 45245
Novartis Investigative Site Terminated
Cleveland, Ohio, United States, 44109-1998
Novartis Investigative Site Active, not recruiting
Columbus, Ohio, United States, 43235
Novartis Investigative Site Active, not recruiting
Dayton, Ohio, United States, 45402
Novartis Investigative Site Active, not recruiting
Marion, Ohio, United States, 43302
Novartis Investigative Site Withdrawn
Toledo, Ohio, United States, 43608
United States, Oklahoma
Novartis Investigative Site Active, not recruiting
Bartlesville, Oklahoma, United States, 74006
Novartis Investigative Site Withdrawn
Oklahoma City, Oklahoma, United States, 73112
Novartis Investigative Site Active, not recruiting
Oklahoma City, Oklahoma, United States, 73120
Novartis Investigative Site Active, not recruiting
Tulsa, Oklahoma, United States, 74133
United States, Oregon
Novartis Investigative Site Active, not recruiting
Bend, Oregon, United States, 97701
Novartis Investigative Site Active, not recruiting
Portland, Oregon, United States, 97225
Novartis Investigative Site Withdrawn
Portland, Oregon, United States, 97239
Novartis Investigative Site Withdrawn
Tualatin, Oregon, United States, 97062
United States, Pennsylvania
Novartis Investigative Site Active, not recruiting
Abington, Pennsylvania, United States, 19001
Novartis Investigative Site Withdrawn
Allentown, Pennsylvania, United States, 18103
Novartis Investigative Site Active, not recruiting
Altoona, Pennsylvania, United States, 16602
Novartis Investigative Site Terminated
Altoona, Pennsylvania, United States, 16602
Novartis Investigative Site Active, not recruiting
Beaver, Pennsylvania, United States, 15009
Novartis Investigative Site Terminated
Bridgeville, Pennsylvania, United States, 15017
Novartis Investigative Site Active, not recruiting
Camp Hill, Pennsylvania, United States, 17011
Novartis Investigative Site Withdrawn
Erie, Pennsylvania, United States, 16506
Novartis Investigative Site Active, not recruiting
Erie, Pennsylvania, United States, 16507
Novartis Investigative Site Active, not recruiting
Hershey, Pennsylvania, United States, 17033-0850
Novartis Investigative Site Terminated
Pittsburgh, Pennsylvania, United States, 15216
Novartis Investigative Site Active, not recruiting
Pittsburgh, Pennsylvania, United States, 15236
Novartis Investigative Site Active, not recruiting
Pittsburgh, Pennsylvania, United States, 15243
Novartis Investigative Site Active, not recruiting
Pottstown, Pennsylvania, United States, 19464
Novartis Investigative Site Withdrawn
Sayre, Pennsylvania, United States, 18840
Novartis Investigative Site Active, not recruiting
Uniontown, Pennsylvania, United States, 15401
United States, Rhode Island
Novartis Investigative Site Active, not recruiting
Cumberland, Rhode Island, United States, 02864-1410
Novartis Investigative Site Withdrawn
Providence, Rhode Island, United States, 02908
Novartis Investigative Site Active, not recruiting
Providence, Rhode Island, United States, 02906
Novartis Investigative Site Active, not recruiting
Providence, Rhode Island, United States, 02904
Novartis Investigative Site Withdrawn
Warwick, Rhode Island, United States, 02886
United States, South Carolina
Novartis Investigative Site Active, not recruiting
Anderson, South Carolina, United States, 29621
Novartis Investigative Site Withdrawn
Charleston, South Carolina, United States, 29401-5799
Novartis Investigative Site Withdrawn
Charleston, South Carolina, United States, 29425
Novartis Investigative Site Terminated
Columbia, South Carolina, United States, 29201
Novartis Investigative Site Active, not recruiting
Fort Mill, South Carolina, United States, 29707
Novartis Investigative Site Active, not recruiting
Greenville, South Carolina, United States, 29605
Novartis Investigative Site Terminated
Greenville, South Carolina, United States, 29605
Novartis Investigative Site Active, not recruiting
Greer, South Carolina, United States, 29651
Novartis Investigative Site Active, not recruiting
Moncks Corner, South Carolina, United States, 29461
Novartis Investigative Site Active, not recruiting
Mt. Pleasant, South Carolina, United States, 29464
Novartis Investigative Site Active, not recruiting
N. Myrtle Beach, South Carolina, United States, 29582
Novartis Investigative Site Active, not recruiting
Orangeburg, South Carolina, United States, 29115
Novartis Investigative Site Withdrawn
Rock Hill, South Carolina, United States, 29732
Novartis Investigative Site Active, not recruiting
Varnville, South Carolina, United States, 29944
United States, South Dakota
Novartis Investigative Site Active, not recruiting
Rapid City, South Dakota, United States, 57701
Novartis Investigative Site Active, not recruiting
Sioux Falls, South Dakota, United States, 57104
United States, Tennessee
Novartis Investigative Site Active, not recruiting
Germantown, Tennessee, United States, 38138
Novartis Investigative Site Active, not recruiting
Jackson, Tennessee, United States, 38305
Novartis Investigative Site Terminated
Johnson City, Tennessee, United States, 37604
Novartis Investigative Site Active, not recruiting
Johnson City, Tennessee, United States, 37604
Novartis Investigative Site Active, not recruiting
Knoxville, Tennessee, United States, 37917
Novartis Investigative Site Active, not recruiting
Knoxville, Tennessee, United States, 37920
Novartis Investigative Site Active, not recruiting
Knoxville, Tennessee, United States, 37934
Novartis Investigative Site Terminated
Memphis, Tennessee, United States, 38120
United States, Texas
Novartis Investigative Site Active, not recruiting
Allen, Texas, United States, 75002-3688
Novartis Investigative Site Active, not recruiting
Beaumont, Texas, United States, 77701
Novartis Investigative Site Active, not recruiting
Beaumont, Texas, United States, 77702
Novartis Investigative Site Active, not recruiting
Bedford, Texas, United States, 76021
Novartis Investigative Site Terminated
Brownsville, Texas, United States, 78520
Novartis Investigative Site Terminated
Dallas, Texas, United States, 75204
Novartis Investigative Site Active, not recruiting
Dallas, Texas, United States, 75226
Novartis Investigative Site Active, not recruiting
Dallas, Texas, United States, 75231
Novartis Investigative Site Active, not recruiting
Gonzales, Texas, United States, 78629
Novartis Investigative Site Withdrawn
Greenville, Texas, United States, 75401
Novartis Investigative Site Active, not recruiting
Greenville, Texas, United States, 75401
Novartis Investigative Site Terminated
Houston, Texas, United States, 77025
Novartis Investigative Site Withdrawn
Houston, Texas, United States, 77030
Novartis Investigative Site Active, not recruiting
Houston, Texas, United States, 77030
Novartis Investigative Site Active, not recruiting
Houston, Texas, United States, 77055
Novartis Investigative Site Terminated
Houston, Texas, United States, 77064
Novartis Investigative Site Active, not recruiting
Houston, Texas, United States, 77070
Novartis Investigative Site Active, not recruiting
Houston, Texas, United States, 77081
Novartis Investigative Site Completed
Irving, Texas, United States, 75039
Novartis Investigative Site Active, not recruiting
Lake Jackson, Texas, United States, 77566
Novartis Investigative Site Active, not recruiting
Leander, Texas, United States, 78641
Novartis Investigative Site Active, not recruiting
Livingston, Texas, United States, 77351
Novartis Investigative Site Active, not recruiting
Lufkin, Texas, United States, 75904
Novartis Investigative Site Completed
Lufkin, Texas, United States, 75904
Novartis Investigative Site Terminated
Marshall, Texas, United States, 75670
Novartis Investigative Site Active, not recruiting
Marshall, Texas, United States, 75670
Novartis Investigative Site Active, not recruiting
McAllen, Texas, United States, 78501
Novartis Investigative Site Active, not recruiting
McKinney, Texas, United States, 75069
Novartis Investigative Site Terminated
Odessa, Texas, United States, 79761
Novartis Investigative Site Active, not recruiting
Pasadena, Texas, United States, 77504
Novartis Investigative Site Completed
Plano, Texas, United States, 75093
Novartis Investigative Site Terminated
San Antonio, Texas, United States, 78258
Novartis Investigative Site Active, not recruiting
San Antonio, Texas, United States, 78229-3900
Novartis Investigative Site Terminated
San Antonio, Texas, United States, 78229-4801
Novartis Investigative Site Active, not recruiting
San Antonio, Texas, United States, 78229
Novartis Investigative Site Active, not recruiting
San Antonio, Texas, United States, 78234
Novartis Investigative Site Active, not recruiting
San Antonio, Texas, United States, 78238-7676
Novartis Investigative Site Active, not recruiting
San Antonio, Texas, United States, 78212
Novartis Investigative Site Withdrawn
Temple, Texas, United States, 76508-0002
Novartis Investigative Site Active, not recruiting
Temple, Texas, United States, 76508
Novartis Investigative Site Active, not recruiting
Tomball, Texas, United States, 77375
Novartis Investigative Site Active, not recruiting
Waco, Texas, United States, 76710
Novartis Investigative Site Terminated
Webster, Texas, United States, 77598
United States, Utah
Novartis Investigative Site Active, not recruiting
Bountiful, Utah, United States, 84010
Novartis Investigative Site Active, not recruiting
Layton, Utah, United States, 84041
Novartis Investigative Site Active, not recruiting
Salt Lake City, Utah, United States, 84102
Novartis Investigative Site Active, not recruiting
Salt Lake City, Utah, United States, 84124
Novartis Investigative Site Terminated
Salt Lake City, Utah, United States, 84107
United States, Virginia
Novartis Investigative Site Terminated
Burke, Virginia, United States, 22015
Novartis Investigative Site Active, not recruiting
Danville, Virginia, United States, 24541
Novartis Investigative Site Active, not recruiting
Hopewell, Virginia, United States, 23860
Novartis Investigative Site Active, not recruiting
Richmond, Virginia, United States, 23249
Novartis Investigative Site Active, not recruiting
Richmond, Virginia, United States, 23298
Novartis Investigative Site Withdrawn
Roanoke, Virginia, United States, 24014
United States, Washington
Novartis Investigative Site Active, not recruiting
Port Orchard, Washington, United States, 98366
Novartis Investigative Site Active, not recruiting
Renton, Washington, United States, 98055
Novartis Investigative Site Active, not recruiting
Seattle, Washington, United States, 98103
Novartis Investigative Site Terminated
Seattle, Washington, United States, 98104
Novartis Investigative Site Withdrawn
Silverdale, Washington, United States, 98383
Novartis Investigative Site Terminated
Tacoma, Washington, United States, 98405
Novartis Investigative Site Active, not recruiting
Tacoma, Washington, United States, 98405
United States, Wisconsin
Novartis Investigative Site Active, not recruiting
Madison, Wisconsin, United States, 53713
Novartis Investigative Site Withdrawn
Wauwatosa, Wisconsin, United States, 53226
Argentina
Novartis Investigative Site Withdrawn
Bahia Blanca, Buenos Aires, Argentina, 8000
Novartis Investigative Site Active, not recruiting
Bahía Blanca, Buenos Aires, Argentina, B8000AAT
Novartis Investigative Site Active, not recruiting
Caba, Buenos Aires, Argentina, C1425AGC
Novartis Investigative Site Active, not recruiting
Caba, Buenos Aires, Argentina, C1056ABJ
Novartis Investigative Site Active, not recruiting
Caba, Buenos Aires, Argentina, C1221ADC
Novartis Investigative Site Active, not recruiting
Caba, Buenos Aires, Argentina, C1425BWO
Novartis Investigative Site Active, not recruiting
Caba, Buenos Aires, Argentina, C1440AAD
Novartis Investigative Site Active, not recruiting
Caba, Buenos Aires, Argentina, 1428
Novartis Investigative Site Withdrawn
Lanus, Buenos Aires, Argentina, B8000XAV
Novartis Investigative Site Active, not recruiting
Mar del Plata, Buenos Aires, Argentina, B7600
Novartis Investigative Site Active, not recruiting
Mar del Plata, Buenos Aires, Argentina, 7600
Novartis Investigative Site Active, not recruiting
Quilmes, Buenos Aires, Argentina, B1878DVB
Novartis Investigative Site Active, not recruiting
Quilmes, Buenos Aires, Argentina, B1878GEG
Novartis Investigative Site Active, not recruiting
Ramos Mejia, Buenos Aires, Argentina, B1704ETD
Novartis Investigative Site Active, not recruiting
San Isidro, Buenos Aires, Argentina, B1642DCD
Novartis Investigative Site Active, not recruiting
San Nicolas, Buenos Aires, Argentina, B2900DMH
Novartis Investigative Site Active, not recruiting
Zarate, Buenos Aires, Argentina, 2800
Novartis Investigative Site Active, not recruiting
Caba, Capital Federal, Argentina, C1425FVH
Novartis Investigative Site Active, not recruiting
Caba, Capital Federal, Argentina, C1179AAB
Novartis Investigative Site Withdrawn
Resistencia, Chaco, Argentina, H3500CDM
Novartis Investigative Site Withdrawn
Villa Maria, Cordoba, Argentina, X5220XAO
Novartis Investigative Site Active, not recruiting
San Salvador de Jujuy, Jujuy, Argentina, Y4600ABF
Novartis Investigative Site Active, not recruiting
Posadas, Misiones, Argentina, N3300AHX
Novartis Investigative Site Active, not recruiting
Cipolletti, Rio Negro, Argentina, 8324
Novartis Investigative Site Active, not recruiting
Tucuman, San Miguel de Tucuman, Argentina, T4000ICL
Novartis Investigative Site Active, not recruiting
Rosario, Santa Fe, Argentina, S2000CXH
Novartis Investigative Site Active, not recruiting
Rosario, Santa Fe, Argentina, S2000DSV
Novartis Investigative Site Active, not recruiting
Rosario, Santa Fe, Argentina, S200CXP
Novartis Investigative Site Terminated
San Miguel de Tucuman, Tucuman, Argentina, T4000EBR
Novartis Investigative Site Active, not recruiting
San Miguel de Tucuman, Tucuman, Argentina, T4000IFL
Novartis Investigative Site Terminated
San Miguel de Tucuman, Tucuman, Argentina, T4000IIH
Novartis Investigative Site Active, not recruiting
Caba, Argentina, C1119ACN
Novartis Investigative Site Completed
Cordoba, Argentina, X5022CPU
Novartis Investigative Site Active, not recruiting
Cordoba, Argentina, X5000AAI
Novartis Investigative Site Terminated
Cordoba, Argentina, X5000AAW
Novartis Investigative Site Active, not recruiting
Cordoba, Argentina, X5000AAX
Novartis Investigative Site Active, not recruiting
Cordoba, Argentina, X5000EPU
Novartis Investigative Site Withdrawn
Cordoba, Argentina, X5000FGG
Novartis Investigative Site Active, not recruiting
Cordoba, Argentina, X5000JJS
Novartis Investigative Site Active, not recruiting
Cordoba, Argentina, X5003DCE
Novartis Investigative Site Active, not recruiting
Cordoba, Argentina, X5003DCP
Novartis Investigative Site Active, not recruiting
Cordoba, Argentina, X5009BSN
Novartis Investigative Site Active, not recruiting
Cordoba, Argentina, 5000
Novartis Investigative Site Active, not recruiting
Cordoba, Argentina, X5220XAO
Novartis Investigative Site Terminated
Corrientes, Argentina, W3410AVV
Novartis Investigative Site Active, not recruiting
Corrientes, Argentina, W3400CLH
Novartis Investigative Site Active, not recruiting
Corrientes, Argentina, W3400
Novartis Investigative Site Active, not recruiting
Corrientes, Argentina, W3400CBI
Novartis Investigative Site Active, not recruiting
Córdoba, Argentina, X5006IKK
Novartis Investigative Site Active, not recruiting
Formosa, Argentina, P3634XAR
Novartis Investigative Site Active, not recruiting
Formosa, Argentina, P3600
Novartis Investigative Site Active, not recruiting
Salta, Argentina, 4400
Novartis Investigative Site Active, not recruiting
San Luis, Argentina, D5702JRS
Novartis Investigative Site Active, not recruiting
Santa Fe, Argentina, S3000EOZ
Novartis Investigative Site Active, not recruiting
Santa Fe, Argentina, S3000EPV
Novartis Investigative Site Active, not recruiting
Santa Fe, Argentina, S3000FWO
Novartis Investigative Site Active, not recruiting
Santiago del Estero, Argentina, G4200AQK
Novartis Investigative Site Active, not recruiting
Tucuman, Argentina, T4000HXU
Australia, Australian Capital Territory
Novartis Investigative Site Active, not recruiting
Garran, Australian Capital Territory, Australia, 2606
Australia, New South Wales
Novartis Investigative Site Active, not recruiting
Gosford, New South Wales, Australia, 2250
Novartis Investigative Site Active, not recruiting
Kogarah, New South Wales, Australia, 2217
Novartis Investigative Site Active, not recruiting
Liverpool, New South Wales, Australia, 2170
Australia, Queensland
Novartis Investigative Site Active, not recruiting
Milton, Queensland, Australia, 4064
Novartis Investigative Site Active, not recruiting
Southport, Queensland, Australia, 4215
Australia, Tasmania
Novartis Investigative Site Active, not recruiting
Hobart, Tasmania, Australia, 7000
Australia, Victoria
Novartis Investigative Site Active, not recruiting
Bundoora, Victoria, Australia, 3083
Novartis Investigative Site Active, not recruiting
Geelong, Victoria, Australia, 3220
Novartis Investigative Site Withdrawn
Melbourne, Victoria, Australia, 3050
Australia, Western Australia
Novartis Investigative Site Terminated
Bateman, Western Australia, Australia, 6150
Novartis Investigative Site Active, not recruiting
Joondalup, Western Australia, Australia, 6027
Novartis Investigative Site Active, not recruiting
Perth, Western Australia, Australia, 6000
Austria
Novartis Investigative Site Withdrawn
Feldbach, Steiermark, Austria, 8330
Novartis Investigative Site Active, not recruiting
Graz, Austria, A-8036
Novartis Investigative Site Active, not recruiting
Linz, Austria, 4010
Novartis Investigative Site Active, not recruiting
Linz, Austria, A-4010
Novartis Investigative Site Withdrawn
Moedling, Austria, A-2340
Novartis Investigative Site Active, not recruiting
Salzburg, Austria, A-5020
Novartis Investigative Site Active, not recruiting
St. Stefan, Austria, 8511
Novartis Investigative Site Active, not recruiting
Vienna, Austria, 1030
Novartis Investigative Site Withdrawn
Wien, Austria, A-1140
Novartis Investigative Site Active, not recruiting
Wien, Austria, A-1090
Belgium
Novartis Investigative Site Active, not recruiting
Aalst, Belgium, 9300
Novartis Investigative Site Active, not recruiting
Bonheiden, Belgium, 2820
Novartis Investigative Site Active, not recruiting
Brasschaat, Belgium, 2930
Novartis Investigative Site Active, not recruiting
Brussel, Belgium, 1000
Novartis Investigative Site Active, not recruiting
De Pinte, Belgium, 9840
Novartis Investigative Site Active, not recruiting
Genk, Belgium, 3600
Novartis Investigative Site Active, not recruiting
Gent, Belgium, 9000
Novartis Investigative Site Active, not recruiting
Hasselt, Belgium, 3500
Novartis Investigative Site Terminated
Huy, Belgium, 4500
Novartis Investigative Site Active, not recruiting
Leuven, Belgium, 3000
Novartis Investigative Site Active, not recruiting
Mechelen, Belgium, 2800
Novartis Investigative Site Active, not recruiting
Ottignies, Belgium, 1340
Novartis Investigative Site Active, not recruiting
Tienen, Belgium, 3300
Brazil
Novartis Investigative Site Active, not recruiting
Salvador, BA, Brazil, 40050-410
Novartis Investigative Site Terminated
Salvador, BA, Brazil, 40140-110
Novartis Investigative Site Active, not recruiting
Fortaleza, CE, Brazil, 60430-370
Novartis Investigative Site Active, not recruiting
Brasilia, DF, Brazil, 70390-903
Novartis Investigative Site Active, not recruiting
Brasilia, DF, Brazil, 70658-700
Novartis Investigative Site Active, not recruiting
Goiania, GO, Brazil, 74223-130
Novartis Investigative Site Active, not recruiting
Goiania, GO, Brazil, 74605-020
Novartis Investigative Site Active, not recruiting
Belo Horizonte, MG, Brazil, 30130-060
Novartis Investigative Site Active, not recruiting
Belo Horizonte, MG, Brazil, 30150-221
Novartis Investigative Site Active, not recruiting
Uberlândia, MG, Brazil, 38400-368
Novartis Investigative Site Terminated
Uberlândia, MG, Brazil, 38405-320
Novartis Investigative Site Active, not recruiting
Campo Grande, MS, Brazil, 79080-190
Novartis Investigative Site Active, not recruiting
Belem, PA, Brazil, 66087-660
Novartis Investigative Site Active, not recruiting
Recife, PE, Brazil, 52051 - 38
Novartis Investigative Site Active, not recruiting
Curitiba, PR, Brazil, 80730-150
Novartis Investigative Site Terminated
Passo Fundo, RS, Brazil, 99010-080
Novartis Investigative Site Active, not recruiting
Pelotas, RS, Brazil, 96015-290
Novartis Investigative Site Withdrawn
Pelotas, RS, Brazil, 96020-220
Novartis Investigative Site Active, not recruiting
Porto Alegre, RS, Brazil, 90880-480
Novartis Investigative Site Active, not recruiting
Porto Alegre, RS, Brazil, 90610-000
Novartis Investigative Site Terminated
Porto Alegre, RS, Brazil, 90620-001
Novartis Investigative Site Active, not recruiting
Porto Alegre, RS, Brazil, 90560-030
Novartis Investigative Site Active, not recruiting
Porto Alegre, RS, Brazil, 91350-200
Novartis Investigative Site Active, not recruiting
Blumenau, SC, Brazil, 89010-500
Novartis Investigative Site Withdrawn
Aracajú, SE, Brazil, 49015-400
Novartis Investigative Site Active, not recruiting
Campinas, SP, Brazil, 13060-904
Novartis Investigative Site Active, not recruiting
Campinas, SP, Brazil, 13020-431
Novartis Investigative Site Active, not recruiting
Campinas, SP, Brazil, 13010-001
Novartis Investigative Site Active, not recruiting
Santo Andre, SP, Brazil, 09190-615
Novartis Investigative Site Withdrawn
Sao Jose do Rio Preto, SP, Brazil, 15015-750
Novartis Investigative Site Active, not recruiting
Sao Jose do Rio Preto, SP, Brazil, 15090-000
Novartis Investigative Site Active, not recruiting
Sao Paulo, SP, Brazil, 01327-010
Novartis Investigative Site Withdrawn
São Paulo, SP, Brazil, 05508-000
Novartis Investigative Site Active, not recruiting
São Paulo, SP, Brazil, 04023-900
Novartis Investigative Site Active, not recruiting
São Paulo, SP, Brazil, 05403-000
Novartis Investigative Site Active, not recruiting
Tatuí, SP, Brazil, 18270-170
Novartis Investigative Site Active, not recruiting
Votuporanga, SP, Brazil, 15500-003
Bulgaria
Novartis Investigative Site Active, not recruiting
Pazardzhik, Bulgaria, 4400
Novartis Investigative Site Active, not recruiting
Pleven, Bulgaria, 5800
Novartis Investigative Site Withdrawn
Plovdiv, Bulgaria, 4004
Novartis Investigative Site Active, not recruiting
Plovdiv, Bulgaria, 4000
Novartis Investigative Site Active, not recruiting
Sofia, Bulgaria, 1606
Novartis Investigative Site Active, not recruiting
Sofia, Bulgaria, 1000
Novartis Investigative Site Active, not recruiting
Sofia, Bulgaria, 1202
Novartis Investigative Site Active, not recruiting
Sofia, Bulgaria, 1233
Novartis Investigative Site Active, not recruiting
Sofia, Bulgaria, 1309
Novartis Investigative Site Active, not recruiting
Sofia, Bulgaria, 1431
Novartis Investigative Site Active, not recruiting
Sofia, Bulgaria, 1527
Canada, British Columbia
Novartis Investigative Site Active, not recruiting
New Westminster, British Columbia, Canada, V3L 3W4
Novartis Investigative Site Active, not recruiting
Surrey, British Columbia, Canada, V3V 1N1
Novartis Investigative Site Active, not recruiting
Victoria, British Columbia, Canada, V8R4R2
Canada, Manitoba
Novartis Investigative Site Active, not recruiting
Winnipeg, Manitoba, Canada, R2V 4W3
Canada, New Brunswick
Novartis Investigative Site Withdrawn
St. John, New Brunswick, Canada, E2L 4L2
Canada, Newfoundland and Labrador
Novartis Investigative Site Active, not recruiting
Mount Pearl, Newfoundland and Labrador, Canada, A1N 1W7
Canada, Nova Scotia
Novartis Investigative Site Active, not recruiting
Halifax, Nova Scotia, Canada, B3H 2Y9
Canada, Ontario
Novartis Investigative Site Active, not recruiting
Cambridge, Ontario, Canada, N1R 6V6
Novartis Investigative Site Active, not recruiting
Etobicoke, Ontario, Canada, M9V 4B4
Novartis Investigative Site Active, not recruiting
Hamilton, Ontario, Canada, L8L 2X2
Novartis Investigative Site Active, not recruiting
Kitchener, Ontario, Canada, N2M 5N4
Novartis Investigative Site Active, not recruiting
Mississauga, Ontario, Canada, L5K 2L3
Novartis Investigative Site Active, not recruiting
Newmarket, Ontario, Canada, L3Y 8C3
Novartis Investigative Site Active, not recruiting
Newmarket, Ontario, Canada, L3Y 2P7
Novartis Investigative Site Active, not recruiting
Ottawa, Ontario, Canada, K1Y 4W7
Novartis Investigative Site Active, not recruiting
Peterborough, Ontario, Canada, K9J 0B2
Novartis Investigative Site Completed
Scarborough, Ontario, Canada, M1P 2V5
Novartis Investigative Site Withdrawn
Thunder Bay, Ontario, Canada, P7B 6V4
Novartis Investigative Site Withdrawn
Toronto, Ontario, Canada, M4N 3M5
Novartis Investigative Site Active, not recruiting
Toronto, Ontario, Canada, M5B 1N9
Novartis Investigative Site Terminated
Toronto, Ontario, Canada, M9W 4L6
Canada, Quebec
Novartis Investigative Site Active, not recruiting
Gatineau, Quebec, Canada, J8Y 6S8
Novartis Investigative Site Active, not recruiting
Granby, Quebec, Canada, J2G 1T7
Novartis Investigative Site Active, not recruiting
Joliette, Quebec, Canada, J6E 6J2
Novartis Investigative Site Active, not recruiting
Lachine, Quebec, Canada, H8S 2E4
Novartis Investigative Site Active, not recruiting
Laval, Quebec, Canada, H7M 3L9
Novartis Investigative Site Active, not recruiting
Longueuil, Quebec, Canada, J4M 2X1
Novartis Investigative Site Active, not recruiting
Loretteville, Quebec, Canada, G2B 5S1
Novartis Investigative Site Active, not recruiting
Lévis, Quebec, Canada, G6V 4Z5
Novartis Investigative Site Active, not recruiting
Montreal, Quebec, Canada, H3G 1A4
Novartis Investigative Site Active, not recruiting
Montreal, Quebec, Canada, H4J 1C5
Novartis Investigative Site Active, not recruiting
Québec, Quebec, Canada, G1G 3Y8
Novartis Investigative Site Active, not recruiting
Sainte-Foy, Quebec, Canada, G1V 4G5
Novartis Investigative Site Active, not recruiting
Sherbrooke, Quebec, Canada, J1G-2E8
Novartis Investigative Site Active, not recruiting
St-Jean-sur-Richelieu, Quebec, Canada, J3A 1C3
Novartis Investigative Site Active, not recruiting
Ste-Foy, Quebec, Canada, G1W 4R4
Novartis Investigative Site Active, not recruiting
Terrebonne, Quebec, Canada, J6V 2H2
Novartis Investigative Site Active, not recruiting
Thetford Mines, Quebec, Canada, G6G 2V4
Canada, Saskatchewan
Novartis Investigative Site Active, not recruiting
Saskatoon, Saskatchewan, Canada, S7H 5M3
Canada
Novartis Investigative Site Active, not recruiting
Quebec, Canada, G1V 4G2
China, Beijing
Novartis Investigative Site Terminated
Beijing, Beijing, China, 100730
China, Chongqing
Novartis Investigative Site Terminated
Chongqing, Chongqing, China, 400010
China, Fujian
Novartis Investigative Site Terminated
Fuzhou, Fujian, China
China, Guangdong
Novartis Investigative Site Active, not recruiting
Guangzhou, Guangdong, China, 510080
China, Guangxi
Novartis Investigative Site Active, not recruiting
Nanning, Guangxi, China, 530021
China, Hebei
Novartis Investigative Site Active, not recruiting
Shijiazhuang, Hebei, China, 050000
China, Heilongjiang
Novartis Investigative Site Active, not recruiting
Harbin, Heilongjiang, China, 150001
China, Hubei
Novartis Investigative Site Terminated
Wuhan, Hubei, China, 430022
Novartis Investigative Site Active, not recruiting
Wuhan, Hubei, China, 430060
China, Hunan
Novartis Investigative Site Active, not recruiting
Changsha, Hunan, China, 410003
China, Jiangsu
Novartis Investigative Site Active, not recruiting
Nanjing, Jiangsu, China, 210009
Novartis Investigative Site Active, not recruiting
Suzhou, Jiangsu, China, 215006
China, Jilin
Novartis Investigative Site Active, not recruiting
Changchun, Jilin, China, 130033
China, Liaoning
Novartis Investigative Site Withdrawn
Dalian, Liaoning, China, 116011
Novartis Investigative Site Active, not recruiting
Shenyang, Liaoning, China, 110003
Novartis Investigative Site Active, not recruiting
Shenyang, Liaoning, China, 110016
China, Shanghai
Novartis Investigative Site Terminated
Shanghai, Shanghai, China, 200120
Novartis Investigative Site Withdrawn
Shanghai, Shanghai, China, 200433
Novartis Investigative Site Active, not recruiting
Shanghai, Shanghai, China
China, Shanxi
Novartis Investigative Site Active, not recruiting
Xi'an, Shanxi, China, 710061
Novartis Investigative Site Active, not recruiting
Xian, Shanxi, China, 710004
China, Tianjin
Novartis Investigative Site Active, not recruiting
Tianjin, Tianjin, China, 300121
China, Zhejiang
Novartis Investigative Site Active, not recruiting
Hangzhou, Zhejiang, China, 310013
Novartis Investigative Site Active, not recruiting
Hangzhou, Zhejiang, China, 310016
China
Novartis Investigative Site Active, not recruiting
Baotou, China, 014040
Novartis Investigative Site Active, not recruiting
Beijing, China, 100176
Novartis Investigative Site Active, not recruiting
Beijing, China, 100028
Novartis Investigative Site Active, not recruiting
Beijing, China, 100029
Novartis Investigative Site Withdrawn
Beijing, China, 100029
Novartis Investigative Site Active, not recruiting
Beijing, China, 100034
Novartis Investigative Site Active, not recruiting
Beijing, China, 100038
Novartis Investigative Site Active, not recruiting
Beijing, China, 100010
Novartis Investigative Site Withdrawn
Guang Zhou, China, 510000
Novartis Investigative Site Active, not recruiting
Guang Zhou City, China, 510000
Novartis Investigative Site Withdrawn
Shanghai, China, 200025
Novartis Investigative Site Withdrawn
Shanghai, China, 200031
Novartis Investigative Site Terminated
Shanghai, China, 200032
Novartis Investigative Site Active, not recruiting
Shanghai, China, 200080
Novartis Investigative Site Active, not recruiting
Tianjin, China, 30045
Novartis Investigative Site Active, not recruiting
Tianjin, China, 300142
Colombia
Novartis Investigative Site Completed
Baranquilla, Atlantico, Colombia
Novartis Investigative Site Withdrawn
Barranquilla, Atlantico, Colombia
Novartis Investigative Site Active, not recruiting
Barranquilla, Atlantico, Colombia
Novartis Investigative Site Active, not recruiting
Cartagena, Bolivar, Colombia
Novartis Investigative Site Completed
Cartagena, Bolivar, Colombia
Novartis Investigative Site Active, not recruiting
Manizales, Caldas, Colombia, 1700
Novartis Investigative Site Active, not recruiting
Bucaramanga, Santander, Colombia
Novartis Investigative Site Active, not recruiting
Floridablanca, Santander, Colombia, 57-7
Novartis Investigative Site Active, not recruiting
Armenia, Colombia
Novartis Investigative Site Active, not recruiting
Baranquilla, Colombia
Novartis Investigative Site Active, not recruiting
Barranquilla, Colombia
Novartis Investigative Site Active, not recruiting
Bogota, Colombia
Novartis Investigative Site Active, not recruiting
Bogotá, Colombia
Novartis Investigative Site Active, not recruiting
Cali, Colombia
Novartis Investigative Site Withdrawn
Cali, Colombia
Novartis Investigative Site Active, not recruiting
Cartegena, Colombia
Novartis Investigative Site Active, not recruiting
Florida Blanca, Colombia
Croatia
Novartis Investigative Site Active, not recruiting
Varazdin, HRV, Croatia, 42000
Novartis Investigative Site Active, not recruiting
Cakovec, Croatia, 40000
Novartis Investigative Site Active, not recruiting
Koprivnica, Croatia, 48000
Novartis Investigative Site Active, not recruiting
Krapinske Toplice, Croatia, 49217
Novartis Investigative Site Active, not recruiting
Krapinske toplice, Croatia, 49 217
Novartis Investigative Site Terminated
Opatija, Croatia, 51410
Novartis Investigative Site Terminated
Rijeka, Croatia, 51000
Novartis Investigative Site Withdrawn
Split, Croatia, 21000
Novartis Investigative Site Active, not recruiting
Virovitica, Croatia, 33000
Novartis Investigative Site Withdrawn
Zagreb, Croatia, 10 000
Novartis Investigative Site Active, not recruiting
Zagreb, Croatia, 10000
Czech Republic
Novartis Investigative Site Active, not recruiting
Most, CZE, Czech Republic, 434 01
Novartis Investigative Site Active, not recruiting
Praha 2, CZE, Czech Republic, 128 08
Novartis Investigative Site Active, not recruiting
Trutnov, CZE, Czech Republic, 46063
Novartis Investigative Site Active, not recruiting
Benesov, Czech Republic, 256 30
Novartis Investigative Site Active, not recruiting
Brandys nad Labem, Czech Republic, 250 01
Novartis Investigative Site Active, not recruiting
Brno-Bohunice, Czech Republic, 639 01
Novartis Investigative Site Active, not recruiting
Broumov, Czech Republic, 550 01
Novartis Investigative Site Active, not recruiting
Jablonec nad Nisou, Czech Republic, 466 01
Novartis Investigative Site Active, not recruiting
Kladno, Czech Republic, 272 80
Novartis Investigative Site Active, not recruiting
Kolin, Czech Republic, 280 20
Novartis Investigative Site Active, not recruiting
Liberec, Czech Republic, 460 05
Novartis Investigative Site Active, not recruiting
Louny, Czech Republic
Novartis Investigative Site Active, not recruiting
Marianske lazne, Czech Republic, 353 01
Novartis Investigative Site Active, not recruiting
Ostrava, Czech Republic, 70200
Novartis Investigative Site Active, not recruiting
Pardubice, Czech Republic, 530 02
Novartis Investigative Site Active, not recruiting
Plzen, Czech Republic, 301 00
Novartis Investigative Site Active, not recruiting
Prague 4 - Krc, Czech Republic, 14059
Novartis Investigative Site Active, not recruiting
Praha 11, Czech Republic, 148 00
Novartis Investigative Site Active, not recruiting
Praha 2, Czech Republic, 128 08
Novartis Investigative Site Active, not recruiting
Praha 9, Czech Republic
Novartis Investigative Site Active, not recruiting
Roznov pod Radhostem, Czech Republic, 756 61
Novartis Investigative Site Terminated
Semily, Czech Republic, 513 31
Novartis Investigative Site Active, not recruiting
Slany, Czech Republic, 274 01
Novartis Investigative Site Active, not recruiting
Svitavy, Czech Republic, 568 25
Novartis Investigative Site Terminated
Teplice, Czech Republic, 415 29
Novartis Investigative Site Active, not recruiting
Trebic, Czech Republic, 674 01
Novartis Investigative Site Active, not recruiting
Uherske Hradiste, Czech Republic, 68601
Novartis Investigative Site Active, not recruiting
Usti nad Labem, Czech Republic, 400 01
Novartis Investigative Site Active, not recruiting
Usti nad Orlici, Czech Republic, 562 18
Novartis Investigative Site Active, not recruiting
Vyskov, Czech Republic, 68001
Novartis Investigative Site Active, not recruiting
Znojmo, Czech Republic, 669 02
Estonia
Novartis Investigative Site Active, not recruiting
Parnu, Estonia, 80010
Novartis Investigative Site Active, not recruiting
Saku, Estonia, 75501
Novartis Investigative Site Terminated
Tallinn, Estonia, 10138
Novartis Investigative Site Active, not recruiting
Tallinn, Estonia, 10138
Novartis Investigative Site Active, not recruiting
Tallinn, Estonia, 10611
Novartis Investigative Site Active, not recruiting
Tallinn, Estonia, 13419
Novartis Investigative Site Active, not recruiting
Tallinn, Estonia, 13619
Novartis Investigative Site Active, not recruiting
Tartu, Estonia, 50410
Novartis Investigative Site Active, not recruiting
Viljandi county, Estonia, 71024
Novartis Investigative Site Active, not recruiting
Võru, Estonia, 65608
Germany
Novartis Investigative Site Active, not recruiting
Bad Krozingen, Germany, 79189
Novartis Investigative Site Active, not recruiting
Balve, Germany, 58802
Novartis Investigative Site Active, not recruiting
Berlin, Germany, 13353
Novartis Investigative Site Active, not recruiting
Berlin, Germany, 10117
Novartis Investigative Site Active, not recruiting
Berlin, Germany, 10629
Novartis Investigative Site Terminated
Berlin, Germany, 10789
Novartis Investigative Site Active, not recruiting
Berlin, Germany, 12627
Novartis Investigative Site Active, not recruiting
Berlin, Germany, 13055
Novartis Investigative Site Active, not recruiting
Berlin, Germany, 10367
Novartis Investigative Site Active, not recruiting
Bochum, Germany, 44787
Novartis Investigative Site Active, not recruiting
Borna, Germany, 04552
Novartis Investigative Site Active, not recruiting
Chemnitz, Germany, 09122
Novartis Investigative Site Withdrawn
Chemnitz, Germany, 09126
Novartis Investigative Site Active, not recruiting
Chemnitz, Germany, 09130
Novartis Investigative Site Active, not recruiting
Dillingen, Germany, 66763
Novartis Investigative Site Terminated
Dinslaken, Germany, 46535
Novartis Investigative Site Withdrawn
Dortmund, Germany, 44137
Novartis Investigative Site Active, not recruiting
Dortmund, Germany, 44137
Novartis Investigative Site Terminated
Dortmund, Germany, 44137
Novartis Investigative Site Active, not recruiting
Dresden, Germany, 01067
Novartis Investigative Site Active, not recruiting
Dresden, Germany, 01069
Novartis Investigative Site Active, not recruiting
Dresden, Germany, 01277
Novartis Investigative Site Active, not recruiting
Dresden, Germany, 01307
Novartis Investigative Site Active, not recruiting
Dresden, Germany, 01309
Novartis Investigative Site Active, not recruiting
Duisburg, Germany, 47137
Novartis Investigative Site Terminated
Düsseldorf, Germany, 40597
Novartis Investigative Site Active, not recruiting
Ebersbach, Germany, 02730
Novartis Investigative Site Active, not recruiting
Elsterwerda, Germany, 04910
Novartis Investigative Site Withdrawn
Erlangen, Germany, 91052
Novartis Investigative Site Active, not recruiting
Erlangen, Germany, 91054
Novartis Investigative Site Active, not recruiting
Essen, Germany, 45355
Novartis Investigative Site Active, not recruiting
Essen, Germany, 45276
Novartis Investigative Site Active, not recruiting
Essen, Germany, 45136
Novartis Investigative Site Active, not recruiting
Falkensee, Germany, 14612
Novartis Investigative Site Terminated
Frankfurt, Germany, 60488
Novartis Investigative Site Active, not recruiting
Frankfurt, Germany, 60594
Novartis Investigative Site Active, not recruiting
Frankfurt am Main, Germany, 60596
Novartis Investigative Site Active, not recruiting
Freiburg, Germany, 79106
Novartis Investigative Site Active, not recruiting
Fulda, Germany, 36037
Novartis Investigative Site Active, not recruiting
Giengen, Germany, 89537
Novartis Investigative Site Completed
Goerlitz, Germany, 02826
Novartis Investigative Site Active, not recruiting
Haag, Germany, 83527
Novartis Investigative Site Active, not recruiting
Halle/'Saale, Germany, 06120
Novartis Investigative Site Active, not recruiting
Hamburg, Germany, 22041
Novartis Investigative Site Active, not recruiting
Hamburg, Germany, 20246
Novartis Investigative Site Active, not recruiting
Hamburg, Germany, 22177
Novartis Investigative Site Active, not recruiting
Hamburg, Germany, 22393
Novartis Investigative Site Active, not recruiting
Hamburg, Germany, 22765
Novartis Investigative Site Active, not recruiting
Heidelberg, Germany, 69120
Novartis Investigative Site Withdrawn
Heidenau, Germany, 01809
Novartis Investigative Site Active, not recruiting
Heilbronn, Germany, 74078
Novartis Investigative Site Withdrawn
Herne, Germany, 44623
Novartis Investigative Site Active, not recruiting
Huy / OT Anderbeck, Germany, 38836
Novartis Investigative Site Active, not recruiting
Jerichow, Germany, 39319
Novartis Investigative Site Active, not recruiting
Kallstadt, Germany, 67169
Novartis Investigative Site Active, not recruiting
Kamp-Lintfort, Germany, 47475
Novartis Investigative Site Terminated
Kassel, Germany, 34127
Novartis Investigative Site Terminated
Kiel, Germany, 24119
Novartis Investigative Site Active, not recruiting
Koblenz, Germany, 56068
Novartis Investigative Site Withdrawn
Krefeld, Germany, 47999
Novartis Investigative Site Active, not recruiting
Kuenzing, Germany, 94550
Novartis Investigative Site Active, not recruiting
Köln, Germany, 51605
Novartis Investigative Site Active, not recruiting
Leipzig, Germany, 04103
Novartis Investigative Site Active, not recruiting
Leipzig, Germany, 04107
Novartis Investigative Site Withdrawn
Lichtenfels, Germany, 96215
Novartis Investigative Site Withdrawn
Limburg, Germany, 65549
Novartis Investigative Site Terminated
Ludwigshafen, Germany, 67063
Novartis Investigative Site Withdrawn
Lutherstadt Wittenberg, Germany, 06886
Novartis Investigative Site Active, not recruiting
Lüneburg, Germany, 21339
Novartis Investigative Site Active, not recruiting
Magdeburg, Germany, 39112
Novartis Investigative Site Active, not recruiting
Mainz, Germany, 55131
Novartis Investigative Site Active, not recruiting
Mainz, Germany, 55116
Novartis Investigative Site Active, not recruiting
Mayen, Germany, 56727
Novartis Investigative Site Active, not recruiting
Meissen, Germany, 01662
Novartis Investigative Site Active, not recruiting
Meißen, Germany, 01662
Novartis Investigative Site Active, not recruiting
Muehldorf am Inn, Germany, 84453
Novartis Investigative Site Active, not recruiting
Muehlhausen, Germany, 99974
Novartis Investigative Site Active, not recruiting
Muhlheim an der Ruhr, Germany, 45468
Novartis Investigative Site Active, not recruiting
Neuhofen, Germany, 67141
Novartis Investigative Site Active, not recruiting
Neunkirchen, Germany, 66539
Novartis Investigative Site Active, not recruiting
Northeim, Germany, 37154
Novartis Investigative Site Active, not recruiting
Nürnberg, Germany, 90402
Novartis Investigative Site Active, not recruiting
Oelde, Germany, 59302
Novartis Investigative Site Active, not recruiting
Oschatz, Germany, 04758
Novartis Investigative Site Active, not recruiting
Paderborn, Germany, 33098
Novartis Investigative Site Active, not recruiting
Potsdam, Germany, 14469
Novartis Investigative Site Active, not recruiting
Rednitzhembach, Germany, 91126
Novartis Investigative Site Withdrawn
Regensburg, Germany, 93051
Novartis Investigative Site Recruiting
Reinfeld, Germany, 23858
Novartis Investigative Site Terminated
Rostock, Germany, 06120
Novartis Investigative Site Withdrawn
Rotenburg a.d. Fulda, Germany, 36199
Novartis Investigative Site Active, not recruiting
Rüdersdorf, Germany, 15562
Novartis Investigative Site Active, not recruiting
Siegen, Germany, 57072
Novartis Investigative Site Active, not recruiting
Ulm, Germany, 89081
Novartis Investigative Site Withdrawn
Wedel, Germany, 22880
Novartis Investigative Site Withdrawn
Weinheim, Germany, 69469
Novartis Investigative Site Withdrawn
Wiesbaden, Germany, 65191
Novartis Investigative Site Withdrawn
Witten, Germany, 58455
Novartis Investigative Site Active, not recruiting
Wolmirstedt, Germany, 39326
Novartis Investigative Site Withdrawn
Zwiesel, Germany, 94227
Greece
Novartis Investigative Site Terminated
Athens, GR, Greece, 106 76
Novartis Investigative Site Active, not recruiting
Athens, GR, Greece, 14233
Novartis Investigative Site Active, not recruiting
Magoula, GR, Greece, 190 18
Novartis Investigative Site Active, not recruiting
Thessaloniki, GR, Greece, 570 10
Novartis Investigative Site Active, not recruiting
Voula, GR, Greece, 166 73
Novartis Investigative Site Active, not recruiting
Athens, Greece, GR 11527
Novartis Investigative Site Active, not recruiting
Athens, Greece, GR 11525
Novartis Investigative Site Active, not recruiting
Chaidari, Greece, GR 12461
Novartis Investigative Site Active, not recruiting
Chalikida, Greece, GR 34100
Novartis Investigative Site Active, not recruiting
Heraklion, Greece, GR 71100
Novartis Investigative Site Active, not recruiting
Heraklion, Greece, GR 71409
Novartis Investigative Site Active, not recruiting
Patras, Greece, GR 26504
Novartis Investigative Site Terminated
Thessaloniki, Greece, GR 56429
Guatemala
Novartis Investigative Site Active, not recruiting
Guatemala City, Guatemala, 01010
Novartis Investigative Site Active, not recruiting
Guatemala City, Guatemala, 01009
Novartis Investigative Site Terminated
Guatemala City, Guatemala, 01010
Novartis Investigative Site Active, not recruiting
Guatemala City, Guatemala, 01011
Novartis Investigative Site Terminated
Guatemala City, Guatemala, 01015
Novartis Investigative Site Active, not recruiting
Guatemala City, Guatemala, 01001
Hungary
Novartis Investigative Site Terminated
Budapest, Hungary, H-1115
Novartis Investigative Site Active, not recruiting
Budapest, Hungary, 1083
Novartis Investigative Site Active, not recruiting
Budapest, Hungary, 1122
Novartis Investigative Site Active, not recruiting
Budapest, Hungary, 1125
Novartis Investigative Site Active, not recruiting
Budapest, Hungary, 1134
Novartis Investigative Site Active, not recruiting
Budapest, Hungary, 1145
Novartis Investigative Site Withdrawn
Budapest, Hungary, H-1096
Novartis Investigative Site Active, not recruiting
Budapest, Hungary, 1042
Novartis Investigative Site Active, not recruiting
Csongrad, Hungary, 6640
Novartis Investigative Site Active, not recruiting
Debrecen, Hungary, 4032
Novartis Investigative Site Active, not recruiting
Gyula, Hungary, 5700
Novartis Investigative Site Active, not recruiting
Kistarcsa, Hungary, 2143
Novartis Investigative Site Active, not recruiting
Komarom, Hungary, 2921
Novartis Investigative Site Active, not recruiting
Miskolc, Hungary, 3530
Novartis Investigative Site Active, not recruiting
Mosonmagyarovar, Hungary, 9200
Novartis Investigative Site Active, not recruiting
Nyiregyháza, Hungary, 4400
Novartis Investigative Site Active, not recruiting
Pecs, Hungary, 7623
Novartis Investigative Site Active, not recruiting
Szeged, Hungary, H-6720
Novartis Investigative Site Active, not recruiting
Szekesfehervar, Hungary, 8000
Novartis Investigative Site Active, not recruiting
Szentes, Hungary, 6600
Novartis Investigative Site Withdrawn
Veszprem, Hungary, H-8200
Novartis Investigative Site Active, not recruiting
Zalaegerszeg, Hungary, 8900
Iceland
Novartis Investigative Site Active, not recruiting
Kopavogur, Iceland, 201
Novartis Investigative Site Active, not recruiting
Reykjavik, Iceland, IS-101
Novartis Investigative Site Terminated
Reykjavik, Iceland, IS-109
India
Novartis Investigative Site Terminated
Hyderabad, Andhra Pradesh, India, 500001
Novartis Investigative Site Withdrawn
Hyderabad, Andhra Pradesh, India, 500004
Novartis Investigative Site Active, not recruiting
Hyderabad, Andhra Pradesh, India
Novartis Investigative Site Terminated
Nampally, Andhra Pradesh, India, 500 001
Novartis Investigative Site Active, not recruiting
Nellore, Andhra Pradesh, India, 524 003
Novartis Investigative Site Active, not recruiting
Secunderabad, Andhra Pradesh, India, 500 003
Novartis Investigative Site Terminated
Secunderabad, Andhra Pradesh, India, 500003
Novartis Investigative Site Active, not recruiting
Tirupati, Andhra Pradesh, India, 517 5-7
Novartis Investigative Site Active, not recruiting
Vijayawada, Andhra Pradesh, India, 520010
Novartis Investigative Site Active, not recruiting
Vijayawada, Andhra Pradesh, India, 520 008
Novartis Investigative Site Active, not recruiting
Vishakhapatnam, Andhra Pradesh, India, 530 013
Novartis Investigative Site Active, not recruiting
Guntur, Andhrapradesh, India, 522001
Novartis Investigative Site Active, not recruiting
New Delhi, Delhi, India, 110060
Novartis Investigative Site Active, not recruiting
Ahmedabad, Gujarat, India, 382428
Novartis Investigative Site Active, not recruiting
Ahmedabad, Gujarat, India, 380006
Novartis Investigative Site Active, not recruiting
Ahmedabad, Gujarat, India, 380 051
Novartis Investigative Site Active, not recruiting
Surat, Gujarat, India, 395001
Novartis Investigative Site Active, not recruiting
Vadodara, Gujarat, India, 390015
Novartis Investigative Site Withdrawn
Gurgaon, Haryana, India, 122001
Novartis Investigative Site Active, not recruiting
Bangalore, Karnataka, India, 560 055
Novartis Investigative Site Active, not recruiting
Bengaluru, Karnataka, India, 560034
Novartis Investigative Site Active, not recruiting
Manipal, Karnataka, India, 576104
Novartis Investigative Site Active, not recruiting
Kochi, Kerala, India, 682 018
Novartis Investigative Site Active, not recruiting
Nagpur, Maharashtra, India, 400012
Novartis Investigative Site Active, not recruiting
Nagpur, Maharashtra, India, 440 010
Novartis Investigative Site Active, not recruiting
Nagpur, Maharashtra, India, 44000033
Novartis Investigative Site Active, not recruiting
Nagpur, Maharashtra, India, 440012
Novartis Investigative Site Active, not recruiting
Nashik, Maharashtra, India, 422 005
Novartis Investigative Site Active, not recruiting
Pune, Maharashtra, India, 411005
Novartis Investigative Site Active, not recruiting
Pune, Maharashtra, India, 411004
Novartis Investigative Site Active, not recruiting
Pune, Maharashtra, India, 411 005
Novartis Investigative Site Withdrawn
Ludhiana, Punjab, India, 141001
Novartis Investigative Site Active, not recruiting
Ludhiana, Punjab, India, 141002
Novartis Investigative Site Active, not recruiting
Ludhiana, Punjab, India, 141421
Novartis Investigative Site Active, not recruiting
Ludhiana, Punjab, India, 141012
Novartis Investigative Site Active, not recruiting
Mohali, Punjab, India, 160 062
Novartis Investigative Site Active, not recruiting
Bikaner, Rajasthan, India, 334003
Novartis Investigative Site Active, not recruiting
Jaipur, Rajasthan, India, 302016
Novartis Investigative Site Active, not recruiting
Jaipur, Rajasthan, India, 302024
Novartis Investigative Site Active, not recruiting
Chennai, Tamil Nadu, India, 600081
Novartis Investigative Site Active, not recruiting
Coimbatore, Tamil Nadu, India, 641037
Novartis Investigative Site Active, not recruiting
Madurai, Tamil Nadu, India, 625107
Novartis Investigative Site Withdrawn
Chennai, Tamilnadu, India, 600096
Novartis Investigative Site Terminated
Coimbatore, Tamilnadu, India, 641 018
Novartis Investigative Site Active, not recruiting
Ghaziabad, Uttar Pradesh, India
Novartis Investigative Site Active, not recruiting
Lucknow, Uttar Pradesh, India, 226005
Novartis Investigative Site Active, not recruiting
Varanasi, Uttar Pradesh, India, 224105
Novartis Investigative Site Active, not recruiting
Ahmedabad, India, 380025
Novartis Investigative Site Active, not recruiting
Ahmedabad, India, 380052
Novartis Investigative Site Active, not recruiting
Hyderabad, India, 500 063
Novartis Investigative Site Withdrawn
New Delhi, India, 110025
Novartis Investigative Site Active, not recruiting
Rajasthan, India, 324005
Italy
Novartis Investigative Site Active, not recruiting
Ancona, AN, Italy, 60128
Novartis Investigative Site Withdrawn
Aosta, AO, Italy, 11100
Novartis Investigative Site Active, not recruiting
Fermo, AP, Italy, 63023
Novartis Investigative Site Active, not recruiting
Cortona, AR, Italy, 52044
Novartis Investigative Site Active, not recruiting
Bergamo, BG, Italy, 24128
Novartis Investigative Site Active, not recruiting
Treviglio, BG, Italy, 24047
Novartis Investigative Site Terminated
Brescia, BS, Italy, 25123
Novartis Investigative Site Terminated
Montichiari, BS, Italy, 25018
Novartis Investigative Site Active, not recruiting
Monserrato, CA, Italy, 09042
Novartis Investigative Site Terminated
Santa Maria Capua Vetere, CE, Italy, 81055
Novartis Investigative Site Active, not recruiting
Chieti, CH, Italy, 66100
Novartis Investigative Site Withdrawn
Cosenza, CS, Italy, 87100
Novartis Investigative Site Active, not recruiting
Catanzaro, CZ, Italy, 88100
Novartis Investigative Site Active, not recruiting
Cona, FE, Italy, 44100
Novartis Investigative Site Active, not recruiting
Foggia, FG, Italy, 71100
Novartis Investigative Site Active, not recruiting
Firenze, FI, Italy, 50134
Novartis Investigative Site Active, not recruiting
Pozzilli, IS, Italy, 86077
Novartis Investigative Site Active, not recruiting
Milano, MI, Italy, 20100
Novartis Investigative Site Active, not recruiting
Milano, MI, Italy, 20132
Novartis Investigative Site Active, not recruiting
Milano, MI, Italy, 20145
Novartis Investigative Site Terminated
Rozzano, MI, Italy, 20089
Novartis Investigative Site Active, not recruiting
Massa, MS, Italy, 54100
Novartis Investigative Site Terminated
Palermo, PA, Italy, 90129
Novartis Investigative Site Active, not recruiting
Piacenza, PC, Italy, 29100
Novartis Investigative Site Withdrawn
Padova, PD, Italy, 35128
Novartis Investigative Site Terminated
Pisa, PI, Italy, 56126
Novartis Investigative Site Withdrawn
Pisa, PI, Italy, 56124
Novartis Investigative Site Active, not recruiting
Parma, PR, Italy, 43100
Novartis Investigative Site Active, not recruiting
Casorate Primo, PV, Italy, 27022
Novartis Investigative Site Active, not recruiting
Pavia, PV, Italy, 27100
Novartis Investigative Site Active, not recruiting
Roma, RM, Italy, 00161
Novartis Investigative Site Withdrawn
Roma, RM, Italy, 00163
Novartis Investigative Site Active, not recruiting
Roma, RM, Italy, 00168
Novartis Investigative Site Active, not recruiting
Roma, RM, Italy, 00189
Novartis Investigative Site Active, not recruiting
Sassari, SS, Italy, 07100
Novartis Investigative Site Active, not recruiting
Palmanova, UD, Italy, 33057
Novartis Investigative Site Active, not recruiting
San Daniele Del Friuli, UD, Italy, 33038
Novartis Investigative Site Terminated
Verona, VR, Italy, 37134
Novartis Investigative Site Terminated
Soriano Calabro, VV, Italy, 89831
Novartis Investigative Site Active, not recruiting
Napoli, Italy, 80131
Novartis Investigative Site Active, not recruiting
Novara, Italy, 28100
Novartis Investigative Site Active, not recruiting
Veruno, Italy, 28010
Japan
Novartis Investigative Site Active, not recruiting
Ichinomiya, Aichi, Japan, 491-8551
Novartis Investigative Site Active, not recruiting
Nagoya-city, Aichi, Japan, 453-8511
Novartis Investigative Site Active, not recruiting
Seto-city, Aichi, Japan, 489-8642
Novartis Investigative Site Active, not recruiting
Funabashi, Chiba, Japan, 273-8588
Novartis Investigative Site Active, not recruiting
Matsudo-city, Chiba, Japan, 270-2251
Novartis Investigative Site Active, not recruiting
Matsudo-city, Chiba, Japan, 271-0077
Novartis Investigative Site Active, not recruiting
Kasuga, Fukuoka, Japan, 816-0864
Novartis Investigative Site Withdrawn
Kitakyushu-city, Fukuoka, Japan, 802-8555
Novartis Investigative Site Active, not recruiting
Kurume-city, Fukuoka, Japan, 830-8577
Novartis Investigative Site Active, not recruiting
Onga-gun, Fukuoka, Japan, 807-0051
Novartis Investigative Site Terminated
Yukuhashi, Fukuoka, Japan, 824-0026
Novartis Investigative Site Active, not recruiting
Ogaki-city, Gifu, Japan, 503-8502
Novartis Investigative Site Active, not recruiting
Fujioka-city, Gunma, Japan, 375-0015
Novartis Investigative Site Active, not recruiting
Takasaki-city, Gunma, Japan, 370-0036
Novartis Investigative Site Active, not recruiting
Hatsukaichi-city, Hiroshima, Japan, 738-8503
Novartis Investigative Site Active, not recruiting
Amagasaki-city, Hyogo, Japan, 660-8550
Novartis Investigative Site Active, not recruiting
Amagasaki-city, Hyogo, Japan, 661-0976
Novartis Investigative Site Withdrawn
Nishinomiya, Hyogo, Japan, 663-8501
Novartis Investigative Site Active, not recruiting
Takarazuka-city, Hyogo, Japan, 665-0022
Novartis Investigative Site Active, not recruiting
Higashiibaraki-gun, Ibaraki, Japan, 311-3193
Novartis Investigative Site Active, not recruiting
Hitachi-city, Ibaraki, Japan, 317-0077
Novartis Investigative Site Withdrawn
Tsukuba, Ibaraki, Japan, 300-0053
Novartis Investigative Site Active, not recruiting
Sakaide-city, Kagawa, Japan, 762-0007
Novartis Investigative Site Active, not recruiting
Takamatsu-city, Kagawa, Japan, 760-8557
Novartis Investigative Site Active, not recruiting
Yokohama-city, Kanagawa, Japan, 234-8503
Novartis Investigative Site Active, not recruiting
Kumamoto City, Kumamoto, Japan, 860-8556
Novartis Investigative Site Active, not recruiting
Kyoto-city, Kyoto, Japan, 607-8062
Novartis Investigative Site Active, not recruiting
Sendai-city, Miyagi, Japan, 983-8520
Novartis Investigative Site Active, not recruiting
Sendai-city, Miyagi, Japan, 980-8574
Novartis Investigative Site Withdrawn
Nagaoka-city, Niigata, Japan, 940-8621
Novartis Investigative Site Active, not recruiting
Hirakata-City, Osaka, Japan, 573-0153
Novartis Investigative Site Active, not recruiting
Osaka-city, Osaka, Japan, 543-0035
Novartis Investigative Site Active, not recruiting
Osaka-city, Osaka, Japan, 543-8555
Novartis Investigative Site Active, not recruiting
Osaka-city, Osaka, Japan, 558-8558
Novartis Investigative Site Withdrawn
Osaka-city, Osaka, Japan, 555-0022
Novartis Investigative Site Active, not recruiting
Takatsuki, Osaka, Japan, 569-0852
Novartis Investigative Site Active, not recruiting
Sayama-city, Saitama, Japan, 350-1305
Novartis Investigative Site Active, not recruiting
Tokorozawa, Saitama, Japan, 359-1142
Novartis Investigative Site Active, not recruiting
Kusatsu-city, Shiga, Japan, 525-0014
Novartis Investigative Site Active, not recruiting
Komatsushima-city, Tokushima, Japan, 773-8502
Novartis Investigative Site Active, not recruiting
Bunkyo-ku, Tokyo, Japan, 113-8603
Novartis Investigative Site Active, not recruiting
Chiyoda-ku, Tokyo, Japan, 101-8309
Novartis Investigative Site Active, not recruiting
Chiyoda-ku, Tokyo, Japan, 101-8643
Novartis Investigative Site Terminated
Fuchu-city, Tokyo, Japan, 183-0003
Novartis Investigative Site Active, not recruiting
Itabashi-ku, Tokyo, Japan, 173-8610
Novartis Investigative Site Active, not recruiting
Nagano, Japan, 380-0814
Korea, Republic of
Novartis Investigative Site Active, not recruiting
Wonju, Gangwon-Do, Korea, Republic of, 220-701
Novartis Investigative Site Active, not recruiting
Suwon, Gyeonggi-do, Korea, Republic of, 443-721
Novartis Investigative Site Active, not recruiting
Uijeongbu-Si, Gyeonggi-do, Korea, Republic of, 480-717
Novartis Investigative Site Withdrawn
Gyeongsangnam-do, Korea, Korea, Republic of, 630-522
Novartis Investigative Site Active, not recruiting
Seoul, Korea, Korea, Republic of, 152-703
Novartis Investigative Site Active, not recruiting
Seoul, Korea, Korea, Republic of, 137-701
Novartis Investigative Site Active, not recruiting
Busan, Korea, Republic of, 602-715
Novartis Investigative Site Active, not recruiting
Busan, Korea, Republic of, 602-739
Novartis Investigative Site Terminated
Busan, Korea, Republic of, 612-896
Novartis Investigative Site Active, not recruiting
Daegu, Korea, Republic of, 705-718
Novartis Investigative Site Active, not recruiting
Daegu, Korea, Republic of, 705-703
Novartis Investigative Site Terminated
Daejeon, Korea, Republic of, 301-747
Novartis Investigative Site Active, not recruiting
Gwangju, Korea, Republic of, 501-757
Novartis Investigative Site Withdrawn
Pusan, Korea, Republic of, 614-735
Novartis Investigative Site Active, not recruiting
Seoul, Korea, Republic of, 120-752
Latvia
Novartis Investigative Site Active, not recruiting
Liepaja, LV, Latvia, LV-3414
Novartis Investigative Site Active, not recruiting
Riga, LV, Latvia, LV-1005
Novartis Investigative Site Active, not recruiting
Ventspils, LV, Latvia, LV-3601
Novartis Investigative Site Active, not recruiting
Daugavplis, Latvia, LV-5417
Novartis Investigative Site Active, not recruiting
Riga, Latvia, 1012
Novartis Investigative Site Withdrawn
Riga, Latvia, LV-1001
Novartis Investigative Site Active, not recruiting
Valmiera, Latvia, 4201
Lithuania
Novartis Investigative Site Active, not recruiting
Kaunas, LTU, Lithuania, 50009
Novartis Investigative Site Active, not recruiting
Alytus, Lithuania, LT-62386
Novartis Investigative Site Active, not recruiting
Kaunas, Lithuania, LT-44320
Novartis Investigative Site Active, not recruiting
Kaunas, Lithuania, LT-49387
Novartis Investigative Site Active, not recruiting
Kaunas, Lithuania, LT-49449
Novartis Investigative Site Active, not recruiting
Kedainiai, Lithuania, LT-57164
Novartis Investigative Site Active, not recruiting
Klaipeda, Lithuania, LT-92288
Novartis Investigative Site Active, not recruiting
Panevezys, Lithuania, LT-37460
Novartis Investigative Site Active, not recruiting
Siauliai, Lithuania, LT-76231
Novartis Investigative Site Withdrawn
Vilnius, Lithuania, 10309
Novartis Investigative Site Active, not recruiting
Vilnius, Lithuania, LT-08661
Mexico
Novartis Investigative Site Active, not recruiting
Guadalajara, Jalisco, Mexico, 44210
Novartis Investigative Site Terminated
Guadalajara, Jalisco, Mexico, 44280
Novartis Investigative Site Active, not recruiting
Culiacan, Sinaloa, Mexico, CP:83230
Novartis Investigative Site Active, not recruiting
Aguascalientes, Mexico, 20230
Novartis Investigative Site Active, not recruiting
Queretaro, Mexico, 76000
Novartis Investigative Site Active, not recruiting
San Luis Potosi, Mexico, 78200
Novartis Investigative Site Active, not recruiting
San Luis Potosí, Mexico, 78240
Netherlands
Novartis Investigative Site Active, not recruiting
Sneek, The Netherlands, Netherlands, 8601 ZR
Novartis Investigative Site Active, not recruiting
Alkmaar, Netherlands, 1815 JD
Novartis Investigative Site Active, not recruiting
Amersfoort, Netherlands, 3813 TZ
Novartis Investigative Site Active, not recruiting
Amstelveen, Netherlands, 1186 AM
Novartis Investigative Site Active, not recruiting
Amsterdam, Netherlands, 1090 HM
Novartis Investigative Site Active, not recruiting
Amsterdam, Netherlands, 1105 AZ
Novartis Investigative Site Active, not recruiting
Apeldoorn, Netherlands, 7334 DZ
Novartis Investigative Site Withdrawn
Beek en Donk, Netherlands, 5741 CG
Novartis Investigative Site Terminated
Breda, Netherlands, 4811SW
Novartis Investigative Site Active, not recruiting
Deventer, Netherlands, 7416 SE
Novartis Investigative Site Active, not recruiting
Doetinchem, Netherlands, 7009 BL
Novartis Investigative Site Active, not recruiting
Ede, Netherlands, 6716 RP
Novartis Investigative Site Active, not recruiting
Gouda, Netherlands, 2800 BB
Novartis Investigative Site Terminated
Groningen, Netherlands, NL-9711 SG
Novartis Investigative Site Active, not recruiting
Haarlem, Netherlands, 2035 RC
Novartis Investigative Site Active, not recruiting
Heerlen, Netherlands, 6419 PC
Novartis Investigative Site Active, not recruiting
Hoorn, Netherlands, 1624 NP
Novartis Investigative Site Active, not recruiting
Leeuwarden, Netherlands, 8934 AD
Novartis Investigative Site Active, not recruiting
Maastricht, Netherlands, 5800
Novartis Investigative Site Active, not recruiting
Meppel, Netherlands, 7943 KA
Novartis Investigative Site Active, not recruiting
Nijmegen, Netherlands
Novartis Investigative Site Terminated
Rotterdam, Netherlands, 3001 HG
Novartis Investigative Site Active, not recruiting
Rotterdam, Netherlands, 3083 AN
Novartis Investigative Site Active, not recruiting
Tiel, Netherlands, 4002 WP
Novartis Investigative Site Active, not recruiting
Utrecht, Netherlands, 3584 CX
Novartis Investigative Site Active, not recruiting
Venlo, Netherlands, 5912 BL
Norway
Novartis Investigative Site Terminated
Elverum, Norway, 2408
Novartis Investigative Site Active, not recruiting
Hamar, Norway, 2317
Novartis Investigative Site Active, not recruiting
Harstad, Norway, 9481
Novartis Investigative Site Withdrawn
Haugesund, Norway, 5527
Novartis Investigative Site Active, not recruiting
Hønefoss, Norway, 3501
Novartis Investigative Site Active, not recruiting
Lillehammer, Norway, 2629
Novartis Investigative Site Active, not recruiting
Moss, Norway, 1523
Novartis Investigative Site Active, not recruiting
Nesttun, Norway, 5221
Novartis Investigative Site Withdrawn
Oslo, Norway, 0160
Novartis Investigative Site Active, not recruiting
Oslo, Norway, 0303
Novartis Investigative Site Active, not recruiting
Oslo, Norway, 0424
Novartis Investigative Site Terminated
Sandefjord, Norway, 3211
Novartis Investigative Site Active, not recruiting
Skedsmokorset, Norway, 2020
Novartis Investigative Site Active, not recruiting
Stavanger, Norway, 4068
Novartis Investigative Site Active, not recruiting
Trondheim, Norway, 7011
Novartis Investigative Site Active, not recruiting
Tynset, Norway, 2501
Novartis Investigative Site Active, not recruiting
Tønsberg, Norway, 3116
Novartis Investigative Site Active, not recruiting
Ålesund, Norway, NO-6026
Peru
Novartis Investigative Site Active, not recruiting
Bellavista, Lima, Peru, Callao 02
Novartis Investigative Site Withdrawn
Cercado de Lima, Lima, Peru, 01
Novartis Investigative Site Terminated
San Isidro, Lima, Peru, 27
Novartis Investigative Site Active, not recruiting
San Martin de Porres, Lima, Peru, 31
Novartis Investigative Site Active, not recruiting
Lima, Peru, Lima 39
Poland
Novartis Investigative Site Terminated
Gdansk, Poland, 80-435
Novartis Investigative Site Active, not recruiting
Gdynia, Poland, 81-157
Novartis Investigative Site Withdrawn
Gdynia, Poland, 81-472
Novartis Investigative Site Terminated
Gdynia, Poland, 81-423
Novartis Investigative Site Active, not recruiting
Gdynia, Poland, 81-302
Novartis Investigative Site Withdrawn
Lodz, Poland, 90-553
Novartis Investigative Site Active, not recruiting
Lublin, Poland, 20-538
Novartis Investigative Site Active, not recruiting
Olawa, Poland, 55-200
Novartis Investigative Site Active, not recruiting
Ostrow Wielkopolski, Poland, 63-400
Novartis Investigative Site Terminated
Poznan, Poland, 60-375
Novartis Investigative Site Terminated
Poznan, Poland, 61-874
Novartis Investigative Site Terminated
Pulawy, Poland, 24-100
Novartis Investigative Site Active, not recruiting
Rumia, Poland, 84-230
Novartis Investigative Site Active, not recruiting
Skierniewice, Poland, 96-100
Novartis Investigative Site Withdrawn
Skierniewice, Poland, 96-100
Novartis Investigative Site Active, not recruiting
Torun, Poland, 87-100
Novartis Investigative Site Withdrawn
Tychy, Poland, 43-100
Novartis Investigative Site Completed
Warszawa, Poland, 04-073
Novartis Investigative Site Active, not recruiting
Wegrow, Poland, 07-100
Novartis Investigative Site Active, not recruiting
Wloclawek, Poland, 87-800
Puerto Rico
Novartis Investigative Site Withdrawn
Barceloneta, Puerto Rico, 00617
Novartis Investigative Site Withdrawn
Cidra, Puerto Rico, 00739
Novartis Investigative Site Active, not recruiting
Manati, Puerto Rico, 00674
Novartis Investigative Site Active, not recruiting
Mayaguez, Puerto Rico, 00680
Novartis Investigative Site Terminated
Ponce, Puerto Rico, 00716
Novartis Investigative Site Active, not recruiting
Ponce, Puerto Rico, 00717
Novartis Investigative Site Withdrawn
Ponce, Puerto Rico, 00733-1471
Novartis Investigative Site Active, not recruiting
San Juan, Puerto Rico, 00909
Novartis Investigative Site Active, not recruiting
San Juan, Puerto Rico, 00926
Novartis Investigative Site Active, not recruiting
San Juan, Puerto Rico, 00936-6528
Novartis Investigative Site Withdrawn
San Juan, Puerto Rico, 00936
Romania
Novartis Investigative Site Withdrawn
Bucharest, District 1, Romania, 11475
Novartis Investigative Site Withdrawn
Bucharest, District 1, Romania
Novartis Investigative Site Active, not recruiting
Bucharest, District 1, Romania
Novartis Investigative Site Withdrawn
Bucuresti, District 1, Romania, 010225
Novartis Investigative Site Active, not recruiting
Bucuresti, District 1, Romania, 010225
Novartis Investigative Site Active, not recruiting
Bucharest, District 2, Romania
Novartis Investigative Site Active, not recruiting
Bucuresti, District 4, Romania, 4204179
Novartis Investigative Site Active, not recruiting
Cluj Napoca, Jud Cluj, Romania, 400015
Novartis Investigative Site Active, not recruiting
Targu Mures, jud Mures, Romania, 540043
Novartis Investigative Site Active, not recruiting
Oradea, Jud. Bihor, Romania, 410169
Novartis Investigative Site Active, not recruiting
Constanta, Jud. Constanta, Romania, 900591
Novartis Investigative Site Active, not recruiting
Craiova, Jud. Dolj, Romania, 200147
Novartis Investigative Site Active, not recruiting
Iasi, Jud. Iasi, Romania, 700005
Novartis Investigative Site Active, not recruiting
Iasi, Jud. Iasi, Romania, 700111
Novartis Investigative Site Active, not recruiting
Timisoara, jud. Timis, Romania, 300359
Novartis Investigative Site Active, not recruiting
Targu Mures, Mures, Romania, 540124
Novartis Investigative Site Active, not recruiting
Tg. Mures, Mures, Romania, 540136
Novartis Investigative Site Active, not recruiting
Baia Mare, Romania, 430123
Novartis Investigative Site Active, not recruiting
Braila, Romania, 810249
Novartis Investigative Site Active, not recruiting
Brasov, Romania, 500281
Novartis Investigative Site Active, not recruiting
Bucharest, Romania, 021659
Novartis Investigative Site Terminated
Bucuresti, Romania, 011774
Novartis Investigative Site Terminated
Bucuresti, Romania, 011728
Novartis Investigative Site Withdrawn
Bucuresti, Romania
Novartis Investigative Site Active, not recruiting
Cluj Napoca, Romania, 400006
Novartis Investigative Site Active, not recruiting
Cluj-Napoca, Romania, 400347
Novartis Investigative Site Active, not recruiting
Craiova, Romania, 200642
Novartis Investigative Site Withdrawn
Hunedoara, Romania, 331057
Novartis Investigative Site Withdrawn
Oradea, Romania, 410169
Novartis Investigative Site Active, not recruiting
Pitesti, Romania, 110114
Novartis Investigative Site Active, not recruiting
Sibiu, Romania, 550371
Novartis Investigative Site Active, not recruiting
Targu Mures, Romania, 540096
Novartis Investigative Site Active, not recruiting
Targu-Mures, Romania, 540136
Novartis Investigative Site Active, not recruiting
Targu-Mures, Romania, 540142
Novartis Investigative Site Withdrawn
Timisoara, Romania, 300014
Novartis Investigative Site Active, not recruiting
Timisoara, Romania, 300310
Novartis Investigative Site Active, not recruiting
Timisoara, Romania, 300736
Russian Federation
Novartis Investigative Site Withdrawn
Barnaul, Russian Federation, 656055
Novartis Investigative Site Active, not recruiting
Chelyabinsk, Russian Federation, 454047
Novartis Investigative Site Active, not recruiting
Chelyabinsk, Russian Federation, 454048
Novartis Investigative Site Active, not recruiting
Chelyabinsk, Russian Federation, 454000
Novartis Investigative Site Active, not recruiting
Ekaterinburg, Russian Federation, 620137
Novartis Investigative Site Active, not recruiting
Ekaterinburg, Russian Federation, 620028
Novartis Investigative Site Active, not recruiting
Ekaterinburg, Russian Federation, 620102
Novartis Investigative Site Active, not recruiting
Ekaterinburg, Russian Federation, 620109
Novartis Investigative Site Active, not recruiting
Izhevsk, Russian Federation, 426063
Novartis Investigative Site Active, not recruiting
Kazan, Russian Federation, 420012
Novartis Investigative Site Active, not recruiting
Kemerovo, Russian Federation, 650029
Novartis Investigative Site Active, not recruiting
Kirov, Russian Federation, 610014
Novartis Investigative Site Active, not recruiting
Kirov, Russian Federation, 610027
Novartis Investigative Site Active, not recruiting
Krasnodar, Russian Federation, 350086
Novartis Investigative Site Active, not recruiting
Moscow, Russian Federation, 111539
Novartis Investigative Site Active, not recruiting
Moscow, Russian Federation, 117198
Novartis Investigative Site Active, not recruiting
Moscow, Russian Federation, 117556
Novartis Investigative Site Withdrawn
Moscow, Russian Federation, 119121
Novartis Investigative Site Active, not recruiting
Moscow, Russian Federation, 119881
Novartis Investigative Site Terminated
Moscow, Russian Federation, 119881
Novartis Investigative Site Withdrawn
Moscow, Russian Federation, 121309
Novartis Investigative Site Active, not recruiting
Moscow, Russian Federation, 125284
Novartis Investigative Site Active, not recruiting
Moscow, Russian Federation, 127018
Novartis Investigative Site Active, not recruiting
Moscow, Russian Federation, 127473
Novartis Investigative Site Withdrawn
N.Novgorod, Russian Federation, 603005
Novartis Investigative Site Active, not recruiting
Novosibirsk, Russian Federation, 630087
Novartis Investigative Site Withdrawn
Omsk, Russian Federation, 644018
Novartis Investigative Site Active, not recruiting
Penza, Russian Federation, 440067
Novartis Investigative Site Terminated
Perm, Russian Federation, 614097
Novartis Investigative Site Terminated
Perm, Russian Federation, 614107
Novartis Investigative Site Active, not recruiting
Petrozavodsk, Russian Federation, 185019
Novartis Investigative Site Active, not recruiting
Ryazan, Russian Federation, 390026
Novartis Investigative Site Terminated
Saint Petersburg, Russian Federation, 195067
Novartis Investigative Site Active, not recruiting
Saint Petersburg, Russian Federation, 197022
Novartis Investigative Site Active, not recruiting
Saint Petersburg, Russian Federation, 199106
Novartis Investigative Site Withdrawn
Saint-Petersburg, Russian Federation, 194044
Novartis Investigative Site Active, not recruiting
Saint-Petersburg, Russian Federation, 195257
Novartis Investigative Site Active, not recruiting
Saint-Petersburg, Russian Federation, 197341
Novartis Investigative Site Active, not recruiting
Samara, Russian Federation, 443096
Novartis Investigative Site Terminated
Samara, Russian Federation, 443070
Novartis Investigative Site Active, not recruiting
Saratov, Russian Federation, 410012
Novartis Investigative Site Active, not recruiting
Saratov, Russian Federation, 410028
Novartis Investigative Site Terminated
Smolensk, Russian Federation, 214018
Novartis Investigative Site Active, not recruiting
St-Petersburg, Russian Federation, 194295
Novartis Investigative Site Active, not recruiting
St-Petersburg, Russian Federation, 196084
Novartis Investigative Site Terminated
St. Petersburg, Russian Federation, 198013
Novartis Investigative Site Active, not recruiting
St. Petersburg, Russian Federation, 197706
Novartis Investigative Site Active, not recruiting
St.- Petersburg, Russian Federation, 197110
Novartis Investigative Site Active, not recruiting
St.-Petersburg, Russian Federation, 194044
Novartis Investigative Site Active, not recruiting
St.Petersburg, Russian Federation, 193163
Novartis Investigative Site Active, not recruiting
Syktyvkar, Russian Federation, 167981
Novartis Investigative Site Active, not recruiting
Tomsk, Russian Federation, 634012
Novartis Investigative Site Active, not recruiting
Tyumen, Russian Federation, 625026
Novartis Investigative Site Active, not recruiting
Vladimir, Russian Federation, 600020
Novartis Investigative Site Terminated
Yaroslavl, Russian Federation, 150047
Serbia
Novartis Investigative Site Withdrawn
Belgrade, Serbia, 11000
Novartis Investigative Site Withdrawn
Beograd, Serbia, 11000
Novartis Investigative Site Active, not recruiting
Beograd, Serbia, 11040
Novartis Investigative Site Active, not recruiting
Nis, Serbia, 18000
Novartis Investigative Site Active, not recruiting
Niska Banja, Serbia, 18205
Novartis Investigative Site Active, not recruiting
Sremska Kamenica, Serbia, 21204
Slovakia
Novartis Investigative Site Active, not recruiting
Bratislava, Slovak Republic, Slovakia, 826 06
Novartis Investigative Site Active, not recruiting
Brezno, Slovak Republic, Slovakia, 977 42
Novartis Investigative Site Active, not recruiting
Komarno, Slovak Republic, Slovakia, 94575
Novartis Investigative Site Active, not recruiting
Kosice, Slovak Republic, Slovakia, 040 22
Novartis Investigative Site Active, not recruiting
Povazska Bystrica, Slovak Republic, Slovakia, 017 01
Novartis Investigative Site Active, not recruiting
Presov, Slovak Republic, Slovakia, 080 01
Novartis Investigative Site Active, not recruiting
Presov, Slovak Republic, Slovakia, 08001
Novartis Investigative Site Active, not recruiting
Rimavska Sobota, Slovak republic, Slovakia, 97901
Novartis Investigative Site Active, not recruiting
Svidnik, Slovak Republic, Slovakia, 08901
Novartis Investigative Site Active, not recruiting
Velky Krtis, Slovak Republic, Slovakia, 990 01
Novartis Investigative Site Active, not recruiting
Banska Bystrica, Slovakia, 97401
Novartis Investigative Site Active, not recruiting
Bardejov, Slovakia, 085 01
Novartis Investigative Site Terminated
Bratislava, Slovakia, 81369
Novartis Investigative Site Active, not recruiting
Bratislava, Slovakia, 831 06
Novartis Investigative Site Withdrawn
Bratislava, Slovakia, 83301
Novartis Investigative Site Active, not recruiting
Bratislava, Slovakia, 841 07
Novartis Investigative Site Active, not recruiting
Dubnica nad Vahom, Slovakia, 01841
Novartis Investigative Site Active, not recruiting
Dunajska Streda, Slovakia, 929 01
Novartis Investigative Site Active, not recruiting
Galanta, Slovakia, 92701
Novartis Investigative Site Active, not recruiting
Kosice, Slovakia, 040 01
Novartis Investigative Site Active, not recruiting
Kosice, Slovakia, 04001
Novartis Investigative Site Withdrawn
Kralovsky Chlmec, Slovakia, 077 01
Novartis Investigative Site Active, not recruiting
Levice, Slovakia, 934 01
Novartis Investigative Site Active, not recruiting
Lucenec, Slovakia, 98403
Novartis Investigative Site Active, not recruiting
Lucenec, Slovakia, 984 01
Novartis Investigative Site Active, not recruiting
Martin, Slovakia, 036 01
Novartis Investigative Site Active, not recruiting
Nitra, Slovakia, 949 01
Novartis Investigative Site Active, not recruiting
Nitra, Slovakia, 94901
Novartis Investigative Site Active, not recruiting
Nove Zamky, Slovakia, 940 01
Novartis Investigative Site Withdrawn
Nove Zamky, Slovakia, 940 01
Novartis Investigative Site Withdrawn
Piestany, Slovakia, 921 01
Novartis Investigative Site Active, not recruiting
Presov, Slovakia, 081 01
Novartis Investigative Site Withdrawn
Rimavska Sobota, Slovakia, 979 01
Novartis Investigative Site Terminated
Trnava, Slovakia, 91702
Novartis Investigative Site Active, not recruiting
Zilina, Slovakia, 012 07
Slovenia
Novartis Investigative Site Active, not recruiting
Celje, Slovenia, 3000
Novartis Investigative Site Active, not recruiting
Golnik, Slovenia, 4204
Novartis Investigative Site Terminated
Ljubljana, Slovenia, 1000
Novartis Investigative Site Withdrawn
Nova Gorica, Slovenia, 5000
South Africa
Novartis Investigative Site Active, not recruiting
Alberton, South Africa, 1449
Novartis Investigative Site Active, not recruiting
Bloemfontein, South Africa, 9301
Novartis Investigative Site Active, not recruiting
Cape Town, South Africa, 7405
Novartis Investigative Site Active, not recruiting
Cape Town, South Africa, 7500
Novartis Investigative Site Active, not recruiting
Cape Town, South Africa, 7925
Novartis Investigative Site Active, not recruiting
Cape Town, South Africa
Novartis Investigative Site Active, not recruiting
Centurion, South Africa, 4001
Novartis Investigative Site Withdrawn
Durban, South Africa, 4001
Novartis Investigative Site Active, not recruiting
Durban, South Africa, 4052
Novartis Investigative Site Withdrawn
Johannesburg, South Africa, 2193
Novartis Investigative Site Active, not recruiting
Johannesburg, South Africa, 2193
Novartis Investigative Site Terminated
Kempton Park, South Africa, 1620
Novartis Investigative Site Terminated
Pretoria, South Africa, 0002
Sweden
Novartis Investigative Site Active, not recruiting
Göteborg, Vastra Gotalands lan, Sweden, SE-413 45
Novartis Investigative Site Active, not recruiting
Boras, Sweden, 506 30
Novartis Investigative Site Active, not recruiting
Göteborg, Sweden, 416 85
Novartis Investigative Site Active, not recruiting
Kristianstad, Sweden, 291 85
Novartis Investigative Site Active, not recruiting
Luleå, Sweden, 972 33
Novartis Investigative Site Active, not recruiting
Lund, Sweden, 221 85
Novartis Investigative Site Active, not recruiting
Lund, Sweden, SE-222 21
Novartis Investigative Site Active, not recruiting
Malmö, Sweden, 214 22
Novartis Investigative Site Active, not recruiting
Mölndal, Sweden, 431 80
Novartis Investigative Site Active, not recruiting
Skanör, Sweden, 239 33
Novartis Investigative Site Active, not recruiting
Skelleftea, Sweden, 931 86
Novartis Investigative Site Active, not recruiting
Stockholm, Sweden, 118 83
Novartis Investigative Site Active, not recruiting
Stockholm, Sweden, SE-111 35
Novartis Investigative Site Active, not recruiting
Uddevalla, Sweden, 451 50
Novartis Investigative Site Active, not recruiting
Vällingby, Sweden, 162 68
Novartis Investigative Site Active, not recruiting
Västerås, Sweden, s-721 89
Novartis Investigative Site Active, not recruiting
Östersund, Sweden, 831 83
Taiwan
Novartis Investigative Site Active, not recruiting
Yungkang, Tainan, Taiwan, 710
Novartis Investigative Site Active, not recruiting
Taichung, Taiwan ROC, Taiwan, 40201
Novartis Investigative Site Active, not recruiting
Taipei, Taiwan, ROC, Taiwan, 112
Novartis Investigative Site Active, not recruiting
Changhua, Taiwan, 500
Novartis Investigative Site Active, not recruiting
Ilan, Taiwan
Novartis Investigative Site Active, not recruiting
Kaohsiung, Taiwan, 807
Novartis Investigative Site Active, not recruiting
Lin-Kou, Taiwan, 33305
Novartis Investigative Site Active, not recruiting
Niaosong Township, Taiwan, 83301
Novartis Investigative Site Active, not recruiting
Taichung, Taiwan, 40447
Novartis Investigative Site Active, not recruiting
Taipei, Taiwan, 10002
Novartis Investigative Site Active, not recruiting
Taipei, Taiwan, 104
Novartis Investigative Site Active, not recruiting
Taipei, Taiwan, 114
Novartis Investigative Site Active, not recruiting
Taipei, Taiwan
Turkey
Novartis Investigative Site Withdrawn
Ankara, Turkey, 06520
Novartis Investigative Site Active, not recruiting
Aydin, Turkey, 09100
Novartis Investigative Site Active, not recruiting
Balcova / Izmir, Turkey, 35340
Novartis Investigative Site Withdrawn
Edirne, Turkey, 22030
Novartis Investigative Site Withdrawn
Etlik / Ankara, Turkey, 06018
Novartis Investigative Site Active, not recruiting
Istanbul, Turkey, 34304
Novartis Investigative Site Active, not recruiting
Izmir, Turkey, 35040
Novartis Investigative Site Active, not recruiting
Kocaeli, Turkey, 41380
Novartis Investigative Site Active, not recruiting
Mersin, Turkey, 33079
Novartis Investigative Site Active, not recruiting
Meselik / Eskisehir, Turkey, 26480
Novartis Investigative Site Active, not recruiting
Sivas, Turkey, 58140
United Kingdom
Novartis Investigative Site Withdrawn
Penzance, Cornwall, United Kingdom, TR19 7HX
Novartis Investigative Site Active, not recruiting
Basingstoke, Hampshire, United Kingdom, RG24 9NA
Novartis Investigative Site Active, not recruiting
Newport, Isle of Wight, United Kingdom, PO30 5TG
Novartis Investigative Site Active, not recruiting
Salford, Manchester, United Kingdom, M6 8HD
Novartis Investigative Site Terminated
Whitby, North Yorkshire, United Kingdom, Y021 1SD
Novartis Investigative Site Terminated
Nottingham, Nottinghamshire, United Kingdom, NG17 4JL
Novartis Investigative Site Active, not recruiting
Dundee, Perthshire, United Kingdom, DD1 9SY
Novartis Investigative Site Active, not recruiting
Axbridge, Somerset, United Kingdom, BS26 2BJ
Novartis Investigative Site Active, not recruiting
Taunton, Somerset, United Kingdom, TA1 5DA
Novartis Investigative Site Withdrawn
Atherstone, Warwickshire, United Kingdom, CV9 1EU
Novartis Investigative Site Active, not recruiting
Barnet, United Kingdom, EN5 3DJ
Novartis Investigative Site Active, not recruiting
Berkshire, United Kingdom, RG2 0TG
Novartis Investigative Site Active, not recruiting
Birmingham, United Kingdom, B15 2SQ
Novartis Investigative Site Active, not recruiting
Birmingham, United Kingdom, B15 2TH
Novartis Investigative Site Active, not recruiting
Birmingham, United Kingdom, B9 5SS
Novartis Investigative Site Withdrawn
Bristol, United Kingdom, BS2 8HW
Novartis Investigative Site Active, not recruiting
Cardiff, United Kingdom, CF5 4AD
Novartis Investigative Site Active, not recruiting
Cardiff, United Kingdom, CF14 5GJ
Novartis Investigative Site Withdrawn
Carshalton, United Kingdom, SH5 1AA
Novartis Investigative Site Terminated
Cheshire, United Kingdom, CW11 1EQ
Novartis Investigative Site Active, not recruiting
Chesterfield, United Kingdom, S40 4AA
Novartis Investigative Site Active, not recruiting
Chorley, United Kingdom, PR7 7NA
Novartis Investigative Site Active, not recruiting
Exeter, United Kingdom, EX2 5DW
Novartis Investigative Site Active, not recruiting
Glasgow, United Kingdom, G20 0SP
Novartis Investigative Site Active, not recruiting
Glasgow, United Kingdom, G20 0XA
Novartis Investigative Site Active, not recruiting
Glasgow, United Kingdom, G51 4TF
Novartis Investigative Site Active, not recruiting
Irvine, United Kingdom, KA12 0AY
Novartis Investigative Site Active, not recruiting
Leicester, United Kingdom, LE3 9QP
Novartis Investigative Site Active, not recruiting
Liverpool, United Kingdom, L22 0LG
Novartis Investigative Site Active, not recruiting
London, United Kingdom, EC14 7BE
Novartis Investigative Site Active, not recruiting
Manchester, United Kingdom, M15 6SX
Novartis Investigative Site Active, not recruiting
Newcastle Upon Tyne, United Kingdom, NE7 7DN
Novartis Investigative Site Active, not recruiting
Newport, United Kingdom, NP20 2UB
Novartis Investigative Site Active, not recruiting
Norwich, United Kingdom, NR4 7UY
Novartis Investigative Site Active, not recruiting
Nottingham, United Kingdom, NG5 1PB
Novartis Investigative Site Active, not recruiting
Sheffield, United Kingdom, S5 7AU
Novartis Investigative Site Withdrawn
West Midlands, United Kingdom, B71 4HJ
Novartis Investigative Site Active, not recruiting
Wiltshire, United Kingdom, SN15 2SB
Novartis Investigative Site Active, not recruiting
Worcester, United Kingdom, WR5 1DD
Novartis Investigative Site Active, not recruiting
York, United Kingdom, YO31 8HE
Sponsors and Collaborators
Novartis Pharmaceuticals
Investigators
Study Director: Novartis Pharmaceuticals Novartis Pharmaceuticals
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Novartis Pharmaceuticals
ClinicalTrials.gov Identifier: NCT01327846     History of Changes
Other Study ID Numbers: CACZ885M2301  2010-022970-14 
Study First Received: March 29, 2011
Last Updated: April 5, 2016
Health Authority: United States: Food and Drug Administration

Keywords provided by Novartis:
Cardiovascular Death
Myocardial Infarction
Stroke
Canakinumab
IL-1B
hsCRP

Additional relevant MeSH terms:
Myocardial Infarction
Atherosclerosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Antibodies, Monoclonal
Immunologic Factors
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on July 27, 2016